Publications from OUS - Dept of Cardiology Ullevaal - Clinical Cardiovascular Research Group

580 publications found

  1. Knudsen Pope M, Hall TS, Virdone S, Atar D, John Camm A, Pieper KS, Jansky P, Haas S, Goto S, Panchenko E, Baron-Esquivias G, Angchaisuksiri P, Kakkar AK, GARFIELD-AF Investigators (2023)
    Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry
    Int J Cardiol Heart Vasc, 49, 101302
    DOI 10.1016/j.ijcha.2023.101302, PubMed 38020059
  2. Kristensen AMD, Munkhaugen J, Halvorsen S, Olsen MH, Bakken A, Sehested TSG, Ruddox V, Lange T, Fagerland MW, Torp-Pedersen C, Prescott E, Atar D (2023)
    The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics
    Eur Heart J Cardiovasc Pharmacother (in press)
    DOI 10.1093/ehjcvp/pvad093, PubMed 38017624
  3. Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, Atar D, Birnie DH, Boriani G, Camm AJ, Conen D, Erath JW, Gold MR, Hohnloser SH, Ip J, Kautzner J, Kutyifa V, Linde C, Mabo P, Mairesse G, Benezet Mazuecos J, Cosedis Nielsen J, Philippon F, Proietti M, Sticherling C et al. (2023)
    Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
    N Engl J Med (in press)
    DOI 10.1056/NEJMoa2310234, PubMed 37952132
  4. Xiong W, Agewall S, Yamashita Y (2023)
    Anticoagulation in Cancer-associated Thrombosis: How Long Should the Therapy Be?
    Eur Heart J Cardiovasc Pharmacother (in press)
    DOI 10.1093/ehjcvp/pvad075, PubMed 37827545
  5. Wärme J, Sundqvist MO, Hjort M, Agewall S, Collste O, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Spaak J, Sörensson P, Y-Hassan S, Svensson P, Lindahl B, Hofmann R, Tornvall P (2023)
    Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease
    Int J Mol Sci, 24 (18)
    DOI 10.3390/ijms241814143, PubMed 37762446
  6. Serebruany VL, Tanguay JF, Gurvich ML, Marciniak TA, Atar D (2023)
    Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy
    Am J Ther, 30 (5), e411-e415
    DOI 10.1097/MJT.0000000000001622, PubMed 37713684
  7. Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF et al. (2023)
    Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
    Cardiovasc Diabetol, 22 (1), 233
    DOI 10.1186/s12933-023-01963-9, PubMed 37653496
  8. Holm NR, Andreasen LN, Neghabat O, Laanmets P, Kumsars I, Bennett J, Olsen NT, Odenstedt J, Hoffmann P, Dens J, Chowdhary S, O'Kane P, Bülow Rasmussen SH, Heigert M, Havndrup O, Van Kuijk JP, Biscaglia S, Mogensen LJH, Henareh L, Burzotta F, H Eek C, Mylotte D, Llinas MS, Koltowski L, Knaapen P et al. (2023)
    OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
    N Engl J Med, 389 (16), 1477-1487
    DOI 10.1056/NEJMoa2307770, PubMed 37634149
  9. Fröhlich H, Bossmeyer A, Kazmi S, Goode KM, Agewall S, Atar D, Grundtvig M, Frey N, Cleland JGF, Frankenstein L, Clark AL, Täger T (2023)
    Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus
    Clin Res Cardiol (in press)
    DOI 10.1007/s00392-023-02268-3, PubMed 37608126
  10. Atar D, Auricchio A, Blomström-Lundqvist C (2023)
    Cardiac device infection: removing barriers to timely and adequate treatment
    Eur Heart J, 44 (35), 3323-3326
    DOI 10.1093/eurheartj/ehad490, PubMed 37529893
  11. Sundqvist MG, Sörensson P, Ekenbäck C, Lundin M, Agewall S, Brolin EB, Cederlund K, Collste O, Daniel M, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Caidahl K, Ugander M, Tornvall P (2023)
    CMR Is Often Abnormal Despite Normal Echocardiography in Suspected Myocardial Infarction With Nonobstructed Coronary Arteries
    JACC Cardiovasc Imaging (in press)
    DOI 10.1016/j.jcmg.2023.05.024, PubMed 37498255
  12. Tjessum L, Agewall S (2023)
    Evaluation of a Structuralized Sick-Leave Programme Compared with usual Care Sick-Leave Management for Patients after an Acute Myocardial Infarction
    J Rehabil Med, 55, jrm4569
    DOI 10.2340/jrm.v55.4569, PubMed 37486246
  13. Gorog DA, Ferreiro JL, Ahrens I, Ako J, Geisler T, Halvorsen S, Huber K, Jeong YH, Navarese EP, Rubboli A, Sibbing D, Siller-Matula JM, Storey RF, Tan JWC, Ten Berg JM, Valgimigli M, Vandenbriele C, Lip GYH (2023)
    De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis
    Nat Rev Cardiol, 20 (12), 830-844
    DOI 10.1038/s41569-023-00901-2, PubMed 37474795
  14. Semb AG, Vesterbekkmo EK, Retterstøl K, Atar D, Solberg EE, Schirmer H, Løchen ML, Kask A, Grimsmo J, Ingul CB, Munkhaugen J (2023)
    [PCSK9 inhibitors on reimbursable prescription: who is eligible?]
    Tidsskr Nor Laegeforen, 143 (8)
    DOI 10.4045/tidsskr.23.0191, PubMed 37254976
  15. Andel PM, Aukrust P, Gleditsch J, Gude E, Haugeberg G, Høie S, Salte T, Steine K, Atar D (2023)
    Recurrent pericarditis
    Tidsskr Nor Laegeforen, 143 (8)
    DOI 10.4045/tidsskr.22.0580, PubMed 37254974
  16. Vinter N, Halminen O, Lehto M, Airaksinen KEJ, Andersson T, Wändell P, Holzmann M, Rutherford OC, Halvorsen S, Cordsen P, Frost L, Johnsen SP (2023)
    Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway and Finland
    Basic Clin Pharmacol Toxicol, 133 (2), 168-178
    DOI 10.1111/bcpt.13902, PubMed 37230945
  17. Tamargo J, Agewall S, Borghi C, Ceconi C, Cerbai E, Dan GA, Ferdinandy P, Grove EL, Rocca B, Sulzgruber P, Semb AG, Sossalla S, Niessner A, Kaski JC, Dobrev D (2023)
    New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
    Eur Heart J Cardiovasc Pharmacother, 9 (4), 353-70 (in press)
    DOI 10.1093/ehjcvp/pvad034, PubMed 37169875
  18. Ratajczak-Tretel B, Lambert AT, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Næss H, Qazi R, Rezaj MK, Rørholt DM, Steffensen LH et al. (2023)
    Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study
    J Neurol, 270 (8), 4049-4059
    DOI 10.1007/s00415-023-11680-8, PubMed 37162578
  19. Halvorsen S, Mehilli J, Geisler T (2023)
    Continue or discontinue aspirin before non-cardiac surgery?
    Eur Heart J, 44 (26), 2410
    DOI 10.1093/eurheartj/ehad246, PubMed 37155334
  20. Jervan Ø, Haukeland-Parker S, Gleditsch J, Tavoly M, Klok FA, Steine K, Johannessen HH, Spruit MA, Atar D, Holst R, Astrup Dahm AE, Sirnes PA, Stavem K, Ghanima W (2023)
    The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
    Chest, 164 (4), 981-991
    DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
  21. Atar D, Bakken A, Munkhaugen J (2023)
    Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction
    Kardiol Pol, 81 (4), 327-329
    DOI 10.33963/KP.a2023.0087, PubMed 37144720
  22. Atar D, Rosseland LA, Jammer I, Aakre KM, Wiseth R, Molund M, Gualandro DM, Omland T (2023)
    Implementing screening for myocardial injury in non-cardiac surgery: perspectives of an ad-hoc interdisciplinary expert group
    Scand Cardiovasc J, 57 (1), 31-39
    DOI 10.1080/14017431.2022.2112071, PubMed 37141087
  23. Knutsen TM, Skretteberg PT, Vanberg P, Kamal Z, Halvorsen S, Liestøl K, Steen T, Platou E (2023)
    Transvenous lead extractions in a single high-volume center over a 24-year period: High success rate and low complication rate
    Heart Rhythm O2, 4 (4), 232-240
    DOI 10.1016/j.hroo.2023.01.003, PubMed 37124554
  24. Valgimigli M, Aboyans V, Angiolillo D, Atar D, Capodanno D, Halvorsen S, James S, Jüni P, Kunadian V, Landi A, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Fox KAA (2023)
    Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
    Eur Heart J Cardiovasc Pharmacother, 9 (5), 462-496
    DOI 10.1093/ehjcvp/pvad032, PubMed 37120728
  25. Halvorsen S, Mehilli J, Mueller C (2023)
    The roles of cardiac troponins before non-cardiac surgery
    Eur Heart J, 44 (23), 2130-2131
    DOI 10.1093/eurheartj/ehad226, PubMed 37098747
  26. Ratajczak-Tretel B, Tancin Lambert A, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth H, Bjerkeli V, Eldøen G, Gulsvik A, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Johansen H, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Næss H, Qazi R, Rezaj MK, Rørholt DM et al. (2022)
    Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
    Eur Stroke J, 8 (1), 148-156
    DOI 10.1177/23969873221123122, PubMed 37021182
  27. Bondjers K, Lingaas I, Stensland S, Atar D, Zwart JA, Wøien H, Dyb G (2023)
    "I've kept going" - a multisite repeated cross-sectional study of healthcare workers' pride in personal performance during the COVID-19 pandemic
    BMC Health Serv Res, 23 (1), 322
    DOI 10.1186/s12913-023-09246-5, PubMed 37004056
  28. Sandberg EL, Halvorsen S, Berge T, Grimsmo J, Atar D, Fensli R, Grenne BL, Jortveit J (2023)
    Fully digital self-screening for atrial fibrillation with patch electrocardiogram
    Europace, 25 (5)
    DOI 10.1093/europace/euad075, PubMed 36945146
  29. Ratajczak-Tretel B, Lambert AT, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ingebrigtsen S, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Naess H, Qazi R, Rezaj MK, Rørholt DM, Steffensen LH, Sømark J et al. (2023)
    Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study - the importance of comprehensive clinical evaluation
    BMC Neurol, 23 (1), 115
    DOI 10.1186/s12883-023-03155-0, PubMed 36944929
  30. Schneider A, Atar D, Agewall S (2023)
    RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action
    J Am Coll Cardiol, 81 (11), 1130-1132
    DOI 10.1016/j.jacc.2022.10.041, PubMed 36922095
  31. Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Kesäniemi YA, Nienaber CA, Ray SG, Rossebø AB, Wachtell K, Nielsen OW (2023)
    Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial
    EClinicalMedicine, 58, 101875
    DOI 10.1016/j.eclinm.2023.101875, PubMed 36915288
  32. Menon V, Halvorsen S (2023)
    The second strategic reperfusion early after myocardial infarction (STREAM-2) study
    Eur Heart J Acute Cardiovasc Care, 12 (4), 219-221
    DOI 10.1093/ehjacc/zuad024, PubMed 36895183
  33. Navarese EP, Landi A, Oliva A, Piccolo R, Aboyans V, Angiolillo D, Atar D, Capodanno D, Fox KAA, Halvorsen S, James S, Jüni P, Kunadian V, Leonardi S, Mehran R, Montalescot G, Niebauer J, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Valgimigli M (2023)
    Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
    Eur Heart J Cardiovasc Pharmacother, 9 (3), 271-290
    DOI 10.1093/ehjcvp/pvad016, PubMed 36869784
  34. Serebruany VL, Tanguay JF, Gurvich ML, Marciniak TA, Atar D (2023)
    Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 Year
    Am J Med, 136 (5), 484-488
    DOI 10.1016/j.amjmed.2023.01.029, PubMed 36828207
  35. Sverre E, Halvorsen S, Løchen ML, Munkhaugen J (2023)
    [E. Sverre et al. respond]
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.23.0062, PubMed 36811436
  36. Tancin Lambert A, Ratajczak-Tretel B, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Johansen H, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Naess H, Qazi R, Rezai MK, Rørholt DM et al. (2023)
    Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study
    Eur J Neurol, 30 (5), 1352-1363
    DOI 10.1111/ene.15746, PubMed 36786305
  37. Nguyen THP, Fagerland MW, Hollan I, Whist JE, Feinberg MW, Agewall S (2023)
    High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis
    PLoS One, 18 (2), e0281155
    DOI 10.1371/journal.pone.0281155, PubMed 36763689
  38. Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristić A, Sade LE, Schirmer H, Schüpke S, Sillesen H, Skulstad H, Torracca L et al. (2023)
    [2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)]
    G Ital Cardiol (Rome), 24 (1 Suppl 1), e1-e102
    DOI 10.1714/3956.39326, PubMed 36645369
  39. Drexel H, Saely CH, Agewall S (2023)
    Fibrates: one more lost paradise in lipid treatment
    Eur Heart J Cardiovasc Pharmacother, 9 (2), 121
    DOI 10.1093/ehjcvp/pvac072, PubMed 36610735
  40. Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G et al. (2023)
    Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Diabetes Metab, 49 (2), 101418
    DOI 10.1016/j.diabet.2022.101418, PubMed 36608816
  41. Nickander J, Ekenbäck C, Agewall S, Bacsovics Brolin E, Caidahl K, Cederlund K, Collste O, Daniel M, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Sundqvist M, Ugander M, Tornvall P, Sörensson P (2022)
    Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
    JACC Cardiovasc Imaging, 16 (1), 128-129
    DOI 10.1016/j.jcmg.2022.07.021, PubMed 36599558
  42. Krychtiuk KA, Ahrens I, Drexel H, Halvorsen S, Hassager C, Huber K, Kurpas D, Niessner A, Schiele F, Semb AG, Sionis A, Claeys MJ, Barrabes J, Montero S, Sinnaeve P, Pedretti R, Catapano A (2022)
    Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Acute Cardiovasc Care, 11 (12), 939-949
    DOI 10.1093/ehjacc/zuac123, PubMed 36574353
  43. Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, Beger B, Brobert G, Casadei B, Ceccarelli C, Cowie MR, Crea F, Cronin M, Denaxas S, Derix A, Fitzsimons D, Fredriksson M, Gale CP, Gkoutos GV, Goettsch W, Hemingway H, Ingvar M, Jonas A, Kazmierski R et al. (2022)
    CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
    BMJ, 378, e069048
    DOI 10.1136/bmj-2021-069048, PubMed 36562446
  44. Hokstad I, Greco D, Deyab G, Fagerland MW, Agewall S, Hjeltnes G, Zimetti F, Bernini F, Ronda N, Hollan I (2022)
    Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
    J Clin Med, 11 (24)
    DOI 10.3390/jcm11247330, PubMed 36555946
  45. Mehilli J, Halvorsen S (2023)
    The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
    Eur Heart J, 44 (5), 336-337
    DOI 10.1093/eurheartj/ehac703, PubMed 36527277
  46. Agewall S (2022)
    Pharmacological treatment of CVD
    Eur Heart J Cardiovasc Pharmacother, 9 (1), 1-3
    DOI 10.1093/ehjcvp/pvac068, PubMed 36519600
  47. Gulati G, Tjessem KH, Horndalsveen H, Halvorsen S, Haakensen VD (2022)
    [Checkpoint inhibitor-induced myocarditis]
    Tidsskr Nor Laegeforen, 142 (18)
    DOI 10.4045/tidsskr.21.0817, PubMed 36511752
  48. Martínez-Montesinos L, Rivera-Caravaca JM, Agewall S, Soler E, Lip GYH, Marín F, Roldán V (2022)
    Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
    Biomed Pharmacother, 158, 114064
    DOI 10.1016/j.biopha.2022.114064, PubMed 36495662
  49. Andreotti F, Geisler T, Collet JP, Gigante B, Gorog DA, Halvorsen S, Lip GYH, Morais J, Navarese EP, Patrono C, Rocca B, Rubboli A, Sibbing D, Storey RF, Verheugt FWA, Vilahur G (2023)
    Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
    Eur Heart J, 44 (4), 262-279
    DOI 10.1093/eurheartj/ehac515, PubMed 36477865
  50. Agewall S (2022)
    To treat or not to treat
    Eur Heart J Cardiovasc Pharmacother, 8 (8), 754-755
    DOI 10.1093/ehjcvp/pvac062, PubMed 36458860
  51. Engebretsen I, Munkhaugen J, Bugge C, Halvorsen S, Ødegaard KM, Støvring H, Kristiansen IS (2022)
    Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs
    Eur Heart J Open, 2 (6), oeac070
    DOI 10.1093/ehjopen/oeac070, PubMed 36440353
  52. Bahlmann E, Einarsen E, Cramariuc D, Pedersen ER, Rossebø AB, Midtbø H, Willems S, Gerdts E (2022)
    Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area
    Open Heart, 9 (2)
    DOI 10.1136/openhrt-2022-002159, PubMed 36428084
  53. Sverre E, Halvorsen S, Løchen ML, Munkhaugen J (2022)
    Personalised cardiovascular disease prevention in the new guidelines
    Tidsskr Nor Laegeforen, 142 (17)
    DOI 10.4045/tidsskr.22.0508, PubMed 36416647
  54. van der Meer D, Gurholt TP, Sønderby IE, Shadrin AA, Hindley G, Rahman Z, de Lange AG, Frei O, Leinhard OD, Linge J, Simon R, Beck D, Westlye LT, Halvorsen S, Dale AM, Karlsen TH, Kaufmann T, Andreassen OA (2022)
    The link between liver fat and cardiometabolic diseases is highlighted by genome-wide association study of MRI-derived measures of body composition
    Commun Biol, 5 (1), 1271
    DOI 10.1038/s42003-022-04237-4, PubMed 36402844
  55. Heiberg E, Engblom H, Carlsson M, Erlinge D, Atar D, Aletras AH, Arheden H (2022)
    Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor data
    J Cardiovasc Magn Reson, 24 (1), 53
    DOI 10.1186/s12968-022-00888-8, PubMed 36336693
  56. Johannessen TR, Halvorsen S, Atar D, Munkhaugen J, Nore AK, Wisløff T, Vallersnes OM (2022)
    Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting
    BMC Health Serv Res, 22 (1), 1274
    DOI 10.1186/s12913-022-08697-6, PubMed 36271364
  57. Ødegaard KM, Lirhus SS, Melberg HO, Hallén J, Halvorsen S (2022)
    Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020
    ESC Heart Fail, 10 (1), 405-415
    DOI 10.1002/ehf2.14206, PubMed 36266969
  58. Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P, Van Der Meer P, Lyon AR, Farmakis D, Lee G, Boriani G, Wechalekar A, Okines A, Asteggiano R, Combes A, Pfister R, Bergler-Klein J, Lettino M (2022)
    Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias
    Eur Heart J Acute Cardiovasc Care, 11 (11), 865-874
    DOI 10.1093/ehjacc/zuac107, PubMed 36226746
  59. Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, Beger B, Brobert G, Casadei B, Ceccarelli C, Cowie MR, Crea F, Cronin M, Denaxas S, Derix A, Fitzsimons D, Fredriksson M, Gale CP, Gkoutos GV, Goettsch W, Hemingway H, Ingvar M, Jonas A, Kazmierski R et al. (2022)
    CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
    Eur Heart J, 43 (37), 3578-3588
    DOI 10.1093/eurheartj/ehac426, PubMed 36208161
  60. von Kemp B, Halvorsen S, Nohria A (2022)
    The new 2022 ESC Guidelines on Cardio-oncology and their impact on the Acute Cardiovascular Care Society
    Eur Heart J Acute Cardiovasc Care, 11 (11), 844-849
    DOI 10.1093/ehjacc/zuac129, PubMed 36205095
  61. Agewall S (2022)
    Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding
    Eur Heart J Cardiovasc Pharmacother, 8 (7), 645-647
    DOI 10.1093/ehjcvp/pvac048, PubMed 36172980
  62. Jortveit J, Pripp AH, Langørgen J, Halvorsen S (2022)
    Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013-19
    Eur Heart J Open, 2 (5), oeac052
    DOI 10.1093/ehjopen/oeac052, PubMed 36071696
  63. Gencer B, Gale CP, Aktaa S, Halvorsen S, Beska B, Abdelhamid M, Mueller C, Tutarel O, McGreavy P, Schirmer H, Geissler T, Sillesen H, Niessner A, Zacharowski K, Mehilli J, Potpara T (2023)
    European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive Care
    Eur Heart J Qual Care Clin Outcomes, 9 (4), 331-341
    DOI 10.1093/ehjqcco/qcac057, PubMed 36069905
  64. Agewall S (2022)
    Prevention is still the key to success
    Eur Heart J Cardiovasc Pharmacother, 8 (6), 537-538
    DOI 10.1093/ehjcvp/pvac046, PubMed 36057770
  65. Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, Beger B, Brobert G, Casadei B, Ceccarelli C, Cowie MR, Crea F, Cronin M, Denaxas S, Derix A, Fitzsimons D, Fredriksson M, Gale CP, Gkoutos GV, Goettsch W, Hemingway H, Ingvar M, Jonas A, Kazmierski R et al. (2022)
    CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research
    Lancet Digit Health, 4 (10), e757-e764
    DOI 10.1016/S2589-7500(22)00151-0, PubMed 36050271
  66. Butt JH, Dewan P, Jhund PS, Anand IS, Atar D, Ge J, Desai AS, Echeverria LE, Køber L, Lam CSP, Maggioni AP, Martinez F, Packer M, Rouleau JL, Sim D, Van Veldhuisen DJ, Vrtovec B, Zannad F, Zile MR, Gong J, Lefkowitz MP, Rizkala AR, Solomon SD, McMurray JJV (2022)
    Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    J Am Coll Cardiol, 80 (12), 1130-1143
    DOI 10.1016/j.jacc.2022.06.037, PubMed 36050227
  67. O'Donoghue ML, Giugliano RP, Wiviott SD, Atar D, Keech A, Kuder JF, Im K, Murphy SA, Flores-Arredondo JH, López JAG, Elliott-Davey M, Wang B, Monsalvo ML, Abbasi S, Sabatine MS (2022)
    Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
    Circulation, 146 (15), 1109-1119
    DOI 10.1161/CIRCULATIONAHA.122.061620, PubMed 36031810
  68. Halvorsen S, Smith JA, Söderdahl F, Thuresson M, Solli O, Ulvestad M, Jonasson C (2022)
    Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
    BMC Prim Care, 23 (1), 214
    DOI 10.1186/s12875-022-01824-6, PubMed 36008778
  69. Triska J, Maitra N, Deshotels MR, Haddadin F, Angiolillo DJ, Vilahur G, Jneid H, Atar D, Birnbaum Y (2022)
    A Comprehensive Review of the Pleiotropic Effects of Ticagrelor
    Cardiovasc Drugs Ther (in press)
    DOI 10.1007/s10557-022-07373-5, PubMed 36001200
  70. Atar D, Sarkar S, Kolev E, Mura C, Brosstad F, Theodorsen L, Westen GI, Stribolt-Halvorsen PE (2022)
    Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet
    Int J Clin Pharmacol Ther, 60 (10), 430-438
    DOI 10.5414/CP204271, PubMed 35979901
  71. Serebruany VL, Tanguay JF, Kuliczkowski W, Heidel E, Kim MH, Atar D (2022)
    Impact of Bleeding on Myocardial Infarction, Stroke, and Death During 12 Months Dual Antiplatelet Therapy After Acute Coronary Syndrome
    Am J Med, 135 (11), 1342-1348
    DOI 10.1016/j.amjmed.2022.07.022, PubMed 35977606
  72. De Caterina R, Agewall S, Andreotti F, Angiolillo DJ, Bhatt DL, Byrne RA, Collet JP, Eikelboom J, Fanaroff AC, Gibson CM, Goette A, Hindricks G, Lip GYH, Potpara T, Thiele H, Lopes RD, Galli M (2022)
    Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
    Eur Heart J, 43 (37), 3512-3527
    DOI 10.1093/eurheartj/ehac294, PubMed 35925556
  73. Tamargo J, Hasegawa K, Agewall S (2022)
    Toward personalized medicine for cardiovascular pharmacotherapy
    Eur Heart J, 43 (45), 4719-4721
    DOI 10.1093/eurheartj/ehac413, PubMed 35924414
  74. Hellgren T, Blöndal M, Jortveit J, Ferenci T, Faxén J, Lewinter C, Eha J, Lõiveke P, Marandi T, Ainla T, Saar A, Veldre G, Andréka P, Halvorsen S, Jánosi A, Edfors R (2022)
    Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries
    Eur Heart J Open, 2 (4), oeac042
    DOI 10.1093/ehjopen/oeac042, PubMed 35919580
  75. Agewall S (2022)
    Focus on optimizing treatment of coronary heart disease
    Eur Heart J Cardiovasc Pharmacother, 8 (5), 431-433
    DOI 10.1093/ehjcvp/pvac039, PubMed 35856265
  76. Tamargo J, Kaski JC, Kimura T, Barton JC, Yamamoto K, Komiyama M, Drexel H, Lewis BS, Agewall S, Hasegawa K (2022)
    Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
    Eur Heart J Cardiovasc Pharmacother, 8 (7), 738-751
    DOI 10.1093/ehjcvp/pvac040, PubMed 35848895
  77. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
    [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]
    G Ital Cardiol (Rome), 23 (6 Suppl 1), e3-e115
    DOI 10.1714/3808.37926, PubMed 35708476
  78. Agewall S (2022)
    Focus on different aspects of atrial fibrillation
    Eur Heart J Cardiovasc Pharmacother, 8 (4), 323-324
    DOI 10.1093/ehjcvp/pvac035, PubMed 35674202
  79. Bahit MC, Vora AN, Li Z, Wojdyla DM, Thomas L, Goodman SG, Aronson R, Jordan JD, Kolls BJ, Dombrowski KE, Vinereanu D, Halvorsen S, Berwanger O, Windecker S, Mehran R, Granger CB, Alexander JH, Lopes RD (2022)
    Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial
    JAMA Cardiol, 7 (7), 682-689
    DOI 10.1001/jamacardio.2022.1166, PubMed 35612866
  80. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Angelantonio ED, Franco OH, Halvorsen S, Richard Hobbs FD, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
    2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
    Rev Esp Cardiol (Engl Ed), 75 (5), 429
    DOI 10.1016/j.rec.2022.04.003, PubMed 35525570
  81. Atar D, Langslet G, Tonstad S (2022)
    Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
    Kardiol Pol, 80 (7-8), 741-749
    DOI 10.33963/KP.a2022.0117, PubMed 35521719
  82. Komiyama M, Agewall S, Hasegawa K (2022)
    Future of antithrombotic therapy for heart failure with coronary artery disease
    Eur Heart J Cardiovasc Pharmacother, 8 (5), e25
    DOI 10.1093/ehjcvp/pvac030, PubMed 35521703
  83. Omland T, Heck SL, Gulati G (2022)
    The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
    JACC CardioOncol, 4 (1), 19-37
    DOI 10.1016/j.jaccao.2022.01.101, PubMed 35492815
  84. Kluge KE, Seljeflot I, Arnesen H, Jensen T, Halvorsen S, Helseth R (2022)
    Coagulation factors XI and XII as possible targets for anticoagulant therapy
    Thromb Res, 214, 53-62
    DOI 10.1016/j.thromres.2022.04.013, PubMed 35490644
  85. Nordeng J, Solheim S, Åkra S, Schandiz H, Hoffmann P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
    Gene expression of fibrinolytic markers in coronary thrombi
    Thromb J, 20 (1), 23
    DOI 10.1186/s12959-022-00383-1, PubMed 35488283
  86. Fyksen TS, Vanberg P, Gjesdal K, von Lueder TG, Bjørnerheim R, Steine K, Atar D, Halvorsen S (2022)
    Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes
    Scand J Med Sci Sports, 32 (8), 1170-1181
    DOI 10.1111/sms.14172, PubMed 35460300
  87. Agewall S (2022)
    New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials
    Eur Heart J Cardiovasc Pharmacother, 8 (3), 213-215
    DOI 10.1093/ehjcvp/pvac019, PubMed 35435962
  88. Korthauer LE, Giugliano RP, Guo J, Sabatine MS, Sever P, Keech A, Atar D, Kurtz C, Ruff CT, Mach F, Ott BR (2022)
    No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
    PLoS One, 17 (4), e0266615
    DOI 10.1371/journal.pone.0266615, PubMed 35404972
  89. Jortveit J, Sandberg EL, Pripp AH, Halvorsen S (2022)
    Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
    Open Heart, 9 (1)
    DOI 10.1136/openhrt-2021-001934, PubMed 35387862
  90. Johannessen TR, Halvorsen S, Atar D, Vallersnes OM (2022)
    Performance of the Novel Observation Group Criteria of the European Society of Cardiology (ESC) 0/1-Hour Algorithm in a Low-Risk Population
    J Am Heart Assoc, 11 (7), e024927
    DOI 10.1161/JAHA.121.024927, PubMed 35352564
  91. Ødegaard KM, Lirhus SS, Melberg HO, Hallén J, Halvorsen S (2022)
    A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
    BMC Cardiovasc Disord, 22 (1), 88
    DOI 10.1186/s12872-022-02522-y, PubMed 35247979
  92. Saldarriaga C, Atar D, Stebbins A, Lewis BS, Abidin IZ, Blaustein RO, Butler J, Ezekowitz JA, Hernandez AF, Lam CSP, O'Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Anstrom KJ, Armstrong PW, VICTORIA Study Group (2022)
    Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
    Eur J Heart Fail, 24 (5), 782-790
    DOI 10.1002/ejhf.2468, PubMed 35239245
  93. Nguyen THP, Hokstad I, Fagerland MW, Mollnes TE, Hollan I, Feinberg MW, Hjeltnes G, Eilertsen GØ, Mikkelsen K, Agewall S (2022)
    Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
    PLoS One, 17 (2), e0264628
    DOI 10.1371/journal.pone.0264628, PubMed 35213675
  94. Welsh RC, Dehghani P, Lopes R, Wojdyla DM, Aronson R, Granger CB, Windecker S, Vora AN, Vinereanu D, Halvorsen S, Parkhomenko A, Mehran R, Alexander JH, Goodman S (2022)
    Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial
    Open Heart, 9 (1)
    DOI 10.1136/openhrt-2021-001892, PubMed 35172988
  95. Ye R, Jneid H, Alam M, Uretsky BF, Atar D, Kitakaze M, Davidson SM, Yellon DM, Birnbaum Y (2022)
    Do We Really Need Aspirin Loading for STEMI?
    Cardiovasc Drugs Ther, 36 (6), 1221-1238
    DOI 10.1007/s10557-022-07327-x, PubMed 35171384
  96. Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Kesäniemi YA, Nienaber CA, Ray SG, Rossebø AB, Willenheimer R, Wachtell K, Nielsen OW (2022)
    Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial
    JAMA Cardiol, 7 (4), 435-444
    DOI 10.1001/jamacardio.2021.5916, PubMed 35171199
  97. Ratajczak-Tretel B, Lambert AT, Atar D, Aamodt AH (2022)
    Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
    Acta Neurol Scand, 145 (5), 641-646
    DOI 10.1111/ane.13590, PubMed 35146751
  98. Tamargo J, Kjeldsen KP, Delpón E, Semb AG, Cerbai E, Dobrev D, Savarese G, Sulzgruber P, Rosano G, Borghi C, Wassmann S, Torp-Pedersen CT, Agewall S, Drexel H, Baumgartner I, Lewis B, Ceconi C, Kaski JC, Niessner A (2022)
    Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 8 (4), 406-419
    DOI 10.1093/ehjcvp/pvac005, PubMed 35092425
  99. Hall TS, Ørn S, Zannad F, Rossignol P, Duarte K, Solomon SD, Atar D, Agewall S, Dickstein K, Girerd N (2022)
    The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction
    J Womens Health (Larchmt), 31 (3), 310-320
    DOI 10.1089/jwh.2021.0326, PubMed 35049355
  100. Agewall S (2022)
    Optimizing individual heart failure treatment
    Eur Heart J Cardiovasc Pharmacother, 8 (2), 105-107
    DOI 10.1093/ehjcvp/pvab087, PubMed 35039827
  101. Moschetti K, Kwong RY, Petersen SE, Lombardi M, Garot J, Atar D, Rademakers FE, Sierra-Galan LM, Mavrogeni S, Li K, Fernandes JL, Schneider S, Pinget C, Ge Y, Antiochos P, Deluigi C, Bruder O, Mahrholdt H, Schwitter J (2022)
    Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries
    JACC Cardiovasc Imaging, 15 (4), 607-625
    DOI 10.1016/j.jcmg.2021.11.008, PubMed 35033498
  102. Birnbaum Y, Rankinen J, Jneid H, Atar D, Nikus K (2022)
    The Role of ECG in the Diagnosis and Risk Stratification of Acute Coronary Syndromes: an Old but Indispensable Tool
    Curr Cardiol Rep, 24 (2), 109-118
    DOI 10.1007/s11886-021-01628-7, PubMed 35028816
  103. Thind M, Zareba W, Atar D, Crijns HJGM, Zhu J, Pak HN, Reiffel J, Ludwigs U, Wieloch M, Stewart J, Kowey P (2022)
    Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials
    Clin Cardiol, 45 (1), 101-109
    DOI 10.1002/clc.23765, PubMed 35019175
  104. Agewall S (2022)
    Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient
    Eur Heart J Cardiovasc Pharmacother, 8 (1), 1-3
    DOI 10.1093/ehjcvp/pvab078, PubMed 34984441
  105. Gulati G (2022)
    Cardioprotection in breast cancer patients: one size fits all?
    Eur Heart J, 43 (27), 2570-2572
    DOI 10.1093/eurheartj/ehab810, PubMed 34951626
  106. Tøllefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen GØ (2021)
    High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001869, PubMed 34933964
  107. Oberprieler NG, Farahmand B, Cameron J, Brobert G, Jonasson C, Atar D (2021)
    Characteristics, treatment patterns, and residual cardiovascular risk of patients with a first acute myocardial infarction: A nationwide population-based cohort study in Norway
    Fundam Clin Pharmacol, 36 (3), 563-571
    DOI 10.1111/fcp.12744, PubMed 34904750
  108. Task Force for the management of COVID-19 of the European Society of Cardiology, Baigent C, Windecker S, Andreini D, Arbelo E, Barbato E, Bartorelli AL, Baumbach A, Behr ER, Berti S, Bueno H, Capodanno D, Cappato R, Chieffo A, Collet JP, Cuisset T, de Simone G, Delgado V, Dendale P, Dudek D, Edvardsen T, Elvan A, González-Juanatey JR, Gori M, Grobbee D et al. (2022)
    European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
    Cardiovasc Res, 118 (6), 1385-1412
    DOI 10.1093/cvr/cvab342, PubMed 34864874
  109. Gonzales RA, Seemann F, Lamy J, Mojibian H, Atar D, Erlinge D, Steding-Ehrenborg K, Arheden H, Hu C, Onofrey JA, Peters DC, Heiberg E (2021)
    MVnet: automated time-resolved tracking of the mitral valve plane in CMR long-axis cine images with residual neural networks: a multi-center, multi-vendor study
    J Cardiovasc Magn Reson, 23 (1), 137
    DOI 10.1186/s12968-021-00824-2, PubMed 34857009
  110. Svenungsson E, Spaak J, Strandberg K, Wallén HN, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Malmqvist K, Elvin K, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P (2021)
    Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries
    J Intern Med, 291 (3), 327-337
    DOI 10.1111/joim.13409, PubMed 34820922
  111. Chiang CH, Chiang CH, Pickering JW, Stoyanov KM, Chew DP, Neumann JT, Ojeda F, Sörensen NA, Su KY, Kavsak P, Worster A, Inoue K, Johannessen TR, Atar D, Amann M, Hochholzer W, Mokhtari A, Ekelund U, Twerenbold R, Mueller C, Bahrmann P, Buttinger N, Dooley M, Ruangsomboon O, Nowak RM et al. (2021)
    Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis
    Ann Intern Med, 175 (1), 101-113
    DOI 10.7326/M21-1499, PubMed 34807719
  112. Sandberg EL, Grenne BL, Berge T, Grimsmo J, Atar D, Halvorsen S, Fensli R, Jortveit J (2021)
    Diagnostic Accuracy and Usability of the ECG247 Smart Heart Sensor Compared to Conventional Holter Technology
    J Healthc Eng, 2021, 5230947
    DOI 10.1155/2021/5230947, PubMed 34765102
  113. Agewall S (2021)
    Unsolved pharmacological issues with cardiology
    Eur Heart J Cardiovasc Pharmacother, 7 (6), 461-462
    DOI 10.1093/ehjcvp/pvab077, PubMed 34734246
  114. Pope MK, Hall TS, Schirripa V, Radic P, Virdone S, Pieper KS, Le Heuzey JY, Jansky P, Fitzmaurice DA, Cappato R, Atar D, Camm AJ, Kakkar AK, GARFIELD-AF investigators (2021)
    Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
    BMJ, 375, e066450
    DOI 10.1136/bmj-2021-066450, PubMed 34706884
  115. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
    2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
    Eur J Prev Cardiol, 29 (1), 5-115
    DOI 10.1093/eurjpc/zwab154, PubMed 34558602
  116. Agewall S (2021)
    More knowledge about atrial fibrillation, still we need to learn
    Eur Heart J Cardiovasc Pharmacother, 7 (5), 361-362
    DOI 10.1093/ehjcvp/pvab067, PubMed 34545933
  117. Täger T, Frankenstein L, Atar D, Agewall S, Frey N, Grundtvig M, Clark AL, Cleland JGF, Fröhlich H (2021)
    Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis
    Clin Res Cardiol, 111 (4), 428-439
    DOI 10.1007/s00392-021-01913-z, PubMed 34498169
  118. Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ (2022)
    Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 8 (1), 100-103
    DOI 10.1093/ehjcvp/pvab063, PubMed 34463331
  119. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2021)
    2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
    Eur Heart J, 42 (34), 3227-3337
    DOI 10.1093/eurheartj/ehab484, PubMed 34458905
  120. Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P, Van Der Meer P, Lyon AR, Farmakis D, Lee G, Boriani G, Wechalekar A, Okines A, Asteggiano R (2021)
    Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases
    Eur Heart J Acute Cardiovasc Care, 10 (8), 947-959
    DOI 10.1093/ehjacc/zuab056, PubMed 34453829
  121. Bahlmann E, Einarsen E, Cramariuc D, Midtbø H, Mancusi C, Rossebø A, Willems S, Gerdts E (2021)
    Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001720, PubMed 34426527
  122. Taegtmeyer H, Atar D (2021)
    Icons in Cardiology
    Cardiology, 146 (6), 667
    DOI 10.1159/000519019, PubMed 34412055
  123. Broberg AM, Tuohinen S, Skytta T, Geisler J, Hrafnkelsdóttir ÞJ, Smáradóttir A, Nielsen KM, Offersen BV, Jarfelt M, Gulati G (2020)
    The Establishment of the Nordic Cardio-Oncology Society
    JACC CardioOncol, 2 (2), 333-335
    DOI 10.1016/j.jaccao.2020.04.004, PubMed 34396242
  124. Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K (2021)
    Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
    EBioMedicine, 70, 103511
    DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947
  125. Agewall S (2021)
    Adherence to pharmacological treatment: how can we improve?
    Eur Heart J Cardiovasc Pharmacother, 7 (4), 261-262
    DOI 10.1093/ehjcvp/pvab049, PubMed 34298551
  126. Rubboli A, Atar D (2021)
    Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?
    Am J Cardiovasc Drugs, 22 (2), 113-115
    DOI 10.1007/s40256-021-00488-4, PubMed 34254254
  127. Allahham M, Lerman A, Atar D, Birnbaum Y (2021)
    Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
    Cardiovasc Drugs Ther, 36 (3), 525-532
    DOI 10.1007/s10557-021-07224-9, PubMed 34245446
  128. Halvorsen S, Johnsen SP, Madsen M, Linder M, Sulo G, Ghanima W, Gislason G, Hohnloser SH, Jenkins A, Al-Khalili F, Tell GS, Ehrenstein V (2022)
    Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
    Eur Heart J Qual Care Clin Outcomes, 8 (5), 577-587
    DOI 10.1093/ehjqcco/qcab048, PubMed 34244745
  129. Deyab G, Reine TM, Vuong TT, Jenssen T, Hjeltnes G, Agewall S, Mikkelsen K, Førre Ø, Fagerland MW, Kolset SO, Hollan I (2021)
    Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
    PLoS One, 16 (7), e0253247
    DOI 10.1371/journal.pone.0253247, PubMed 34242246
  130. Drexel H, Pocock SJ, Lewis BS, Saely CH, Kaski JC, Rosano GMC, Tautermann G, Huber K, Dopheide JF, Mader A, Niessner A, Savarese G, Schmidt TA, Semb AG, Tamargo J, Wassmann S, Clodi M, Kjeldsen KP, Agewall S (2022)
    Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 8 (3), 302-310
    DOI 10.1093/ehjcvp/pvab048, PubMed 34180504
  131. Nguyen THP, Fagerland MW, Deyab G, Hjeltnes G, Hollan I, Feinberg MW, Eilertsen GØ, Mikkelsen K, Agewall S (2021)
    Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
    PLoS One, 16 (6), e0253793
    DOI 10.1371/journal.pone.0253793, PubMed 34170978
  132. Rubboli A, Atar D (2021)
    The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused
    Eur J Intern Med, 90, 125-126
    DOI 10.1016/j.ejim.2021.05.009, PubMed 34090747
  133. Ghanima W, Schultze A, Donaldson R, Brodin E, Halvorsen S, Graham S, Carroll R, Ulvestad M, Lambrelli D (2021)
    Oral Anticoagulation Therapy for Venous Thromboembolism in Norway: Time Trends and Treatment Patterns
    Clin Ther, 43 (7), 1179-1190.e3
    DOI 10.1016/j.clinthera.2021.04.017, PubMed 34083030
  134. Chieffo A, Dudek D, Hassager C, Combes A, Gramegna M, Halvorsen S, Huber K, Kunadian V, Maly J, Møller JE, Pappalardo F, Tarantini G, Tavazzi G, Thiele H, Vandenbriele C, van Mieghem N, Vranckx P, Werner N, Price S (2021)
    Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
    Eur Heart J Acute Cardiovasc Care, 10 (5), 570-583
    DOI 10.1093/ehjacc/zuab015, PubMed 34057173
  135. Chieffo A, Dudek D, Hassager C, Combes A, Gramegna M, Halvorsen S, Huber K, Kunadian V, Maly J, Møller JE, Pappalardo F, Tarantini G, Tavazzi G, Thiele H, Vandenbriele C, Van Mieghem N, Vranckx P, Werner N, Price S (2021)
    Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
    EuroIntervention, 17 (4), e274-e286
    DOI 10.4244/EIJY21M05_01, PubMed 34057071
  136. Rønning P, Helseth E, Skaansar O, Tverdal C, Andelic N, Bhatnagar R, Melberg M, Skaga NO, Aarhus M, Halvorsen S, Helseth R (2021)
    Impact of Preinjury Antithrombotic Therapy on 30-Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)
    Front Neurol, 12, 650695
    DOI 10.3389/fneur.2021.650695, PubMed 34054695
  137. Agewall S (2021)
    Different aspects of giving the optimal antiplatelet treatment
    Eur Heart J Cardiovasc Pharmacother, 7 (3), 169-170
    DOI 10.1093/ehjcvp/pvab037, PubMed 34023878
  138. Heck SL, Mecinaj A, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, Røsjø H, Steine K, Geisler J, Gulati G, Omland T (2021)
    Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
    Circulation, 143 (25), 2431-2440
    DOI 10.1161/CIRCULATIONAHA.121.054698, PubMed 33993702
  139. Rutherford OW, Jonasson C, Ghanima W, Söderdahl F, Halvorsen S (2021)
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
    Heart, 108 (5), 345-352
    DOI 10.1136/heartjnl-2020-318753, PubMed 33975877
  140. Krogager ML, Kragholm K, Thomassen JQ, Søgaard P, Lewis BS, Wassmann S, Baumgartner I, Ceconi C, Schmidt TA, Kaski JC, Drexel H, Semb AG, Agewall S, Niessner A, Savarese G, Kjeldsen KP, Borghi C, Tamargo J, Torp-Pedersen C (2021)
    Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 7 (6), 557-567
    DOI 10.1093/ehjcvp/pvab038, PubMed 33956964
  141. Hall TS, Atar D (2021)
    The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation
    Eur J Intern Med, 88, 21-22
    DOI 10.1016/j.ejim.2021.04.008, PubMed 33934970
  142. Peterson BE, Bhatt DL, Gabriel Steg P, Oldgren J, Maeng M, Zeymer U, Halvorsen S, Hohnloser SH, Lip GYH, Kimura T, Nordaby M, Miede C, Kleine E, Ten Berg JM, Cannon CP, RE-DUAL PCI Steering Committee and Investigators (2021)
    Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
    JACC Cardiovasc Interv, 14 (7), 768-780
    DOI 10.1016/j.jcin.2021.02.022, PubMed 33826497
  143. Pope MK, Atar D, Svilaas A, Hole T, Nielsen JD, Hintze U, Crisby M, Raatikainen P, Airaksinen KEJ, Virdone S, Pieper K, Kayani G, Le Heuzey JY, Steffel J, Stepinska J, Bassand JP, Camm AJ, GARFIELD-AF Investigators (2021)
    Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry
    Ann Med, 53 (1), 485-494
    DOI 10.1080/07853890.2021.1893897, PubMed 33818226
  144. Agewall S (2021)
    Antiplatelet treatment in coronary syndrome
    Eur Heart J Cardiovasc Pharmacother, 7 (2), 81-82
    DOI 10.1093/ehjcvp/pvab015, PubMed 33720341
  145. Blöndal M, Ainla T, Eha J, Lõiveke P, Marandi T, Saar A, Veldre G, Edfors R, Lewinter C, Jernberg T, Jortveit J, Halvorsen S, Becker D, Csanádi Z, Ferenci T, Andréka P, Jánosi A (2022)
    Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries
    Eur Heart J Qual Care Clin Outcomes, 8 (3), 307-314
    DOI 10.1093/ehjqcco/qcaa098, PubMed 33710273
  146. Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ (2022)
    The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 8 (1), 85-99
    DOI 10.1093/ehjcvp/pvab018, PubMed 33638977
  147. Johannessen TR, Atar D, Vallersnes OM, Larstorp ACK, Mdala I, Halvorsen S (2021)
    Comparison of a single high-sensitivity cardiac troponin T measurement with the HEART score for rapid rule-out of acute myocardial infarction in a primary care emergency setting: a cohort study
    BMJ Open, 11 (2), e046024
    DOI 10.1136/bmjopen-2020-046024, PubMed 33627355
  148. Krychtiuk KA, Speidl WS, Giannitsis E, Gigante B, Gorog DA, Jaffe AS, Mair J, Möckel M, Mueller C, Storey RF, Vilahur G, Wojta J, Huber K, Halvorsen S, Geisler T, Morais J, Lindahl B, Thygesen K (2021)
    Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis
    Eur Heart J Acute Cardiovasc Care, 10 (3), 343-355
    DOI 10.1093/ehjacc/zuaa025, PubMed 33620437
  149. Edfors R, Jernberg T, Lewinter C, Blöndal M, Eha J, Lõiveke P, Marandi T, Ainla T, Saar A, Veldre G, Ferenci T, Andréka P, Jánosi A, Jortveit J, Halvorsen S (2022)
    Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries
    Eur Heart J Qual Care Clin Outcomes, 8 (4), 429-436
    DOI 10.1093/ehjqcco/qcab013, PubMed 33605415
  150. Schiele F, Aktaa S, Rossello X, Ahrens I, Claeys MJ, Collet JP, Fox KAA, Gale CP, Huber K, Iakobishvili Z, Keys A, Lambrinou E, Leonardi S, Lettino M, Masoudi FA, Price S, Quinn T, Swahn E, Thiele H, Timmis A, Tubaro M, Vrints CJM, Walker D, Bueno H, ESC Scientific Document Group et al. (2021)
    2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group
    Eur Heart J Acute Cardiovasc Care, 10 (2), 224-233
    DOI 10.1093/ehjacc/zuaa037, PubMed 33550362
  151. Birnbaum Y, Nikus K, Atar D, Jneid H (2021)
    Is RBBB the new LBBB? Are we going to repeat the same mistakes?
    J Electrocardiol, 65, 34-36
    DOI 10.1016/j.jelectrocard.2020.12.010, PubMed 33477070
  152. Atar D, Jukema JW, Molemans B, Taub PR, Goto S, Mach F, CerezoOlmos C, Underberg J, Keech A, Tokgözoğlu L, Bonaca MP (2021)
    New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
    Atherosclerosis, 319, 51-61
    DOI 10.1016/j.atherosclerosis.2020.12.013, PubMed 33476944
  153. Hijazi Z, Alexander JH, Li Z, Wojdyla DM, Mehran R, Granger CB, Parkhomenko A, Bahit MC, Windecker S, Aronson R, Berwanger O, Halvorsen S, de Waha-Thiele S, Sinnaeve P, Darius H, Storey RF, Lopes RD (2021)
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
    Circulation, 143 (12), 1215-1223
    DOI 10.1161/CIRCULATIONAHA.120.051020, PubMed 33461308
  154. Camm AJ, Atar D (2021)
    Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects
    Thromb Haemost, 121 (6), 716-730
    DOI 10.1055/s-0040-1721665, PubMed 33412613
  155. Agewall S (2021)
    Atrial fibrillation in registries
    Eur Heart J Cardiovasc Pharmacother, 7 (1), 1-2
    DOI 10.1093/ehjcvp/pvaa142, PubMed 33367509
  156. De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, Lopes RD, McMurray JJV, Atar D, Bahit MC, Keltai M, López-Sendón JL, Ruzyllo W, Granger CB, Alexander JH, Wallentin L (2022)
    Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
    Eur Heart J Cardiovasc Pharmacother, 8 (3), 227-235
    DOI 10.1093/ehjcvp/pvaa140, PubMed 33367487
  157. Sinning C, Ahrens I, Cariou A, Beygui F, Lamhaut L, Halvorsen S, Nikolaou N, Nolan JP, Price S, Monsieurs K, Behringer W, Cecconi M, Van Belle E, Jouven X, Hassager C (2020)
    The cardiac arrest centre for the treatment of sudden cardiac arrest due to presumed cardiac cause - aims, function and structure: Position paper of the Association for Acute CardioVascular Care of the European Society of Cardiology (AVCV), European Association of Percutaneous Coronary Interventions (EAPCI), European Heart Rhythm Association (EHRA), European Resuscitation Council (ERC), European Society for Emergency Medicine (EUSEM) and European Society of Intensive Care Medicine (ESICM)
    Eur Heart J Acute Cardiovasc Care, 9 (4_suppl), S193-S202
    DOI 10.1177/2048872620963492, PubMed 33327761
  158. Blichfeldt-Ærø SC, Knutsen TM, Hagen HM, Diep LM, Trondalen G, Halvorsen S (2020)
    Music therapy as an adjunct in cardiac device lead extraction procedures: A randomized controlled trial
    Appl Nurs Res, 56, 151376
    DOI 10.1016/j.apnr.2020.151376, PubMed 33280783
  159. Agewall S (2020)
    Focus on blood pressure and risk factor intervention
    Eur Heart J Cardiovasc Pharmacother, 6 (6), 339-340
    DOI 10.1093/ehjcvp/pvaa130, PubMed 33197927
  160. Cramariuc D, Bahlmann E, Egstrup K, Rossebø AB, Ray S, Kesäniemi YA, Nienaber CA, Gerdts E (2020)
    Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis
    Echocardiography, 38 (1), 31-38
    DOI 10.1111/echo.14916, PubMed 33146452
  161. Maqsood MH, Alam M, Atar D, Birnbaum Y (2021)
    Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis
    J Cardiovasc Pharmacol, 77 (1), 87-93
    DOI 10.1097/FJC.0000000000000922, PubMed 33136764
  162. Drexel H, Lewis BS, Rosano GMC, Saely CH, Tautermann G, Huber K, Dopheide JF, Kaski JC, Mader A, Niessner A, Savarese G, Schmidt TA, Semb A, Tamargo J, Wassmann S, Per Kjeldsen K, Agewall S, Pocock SJ (2021)
    The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
    Eur Heart J Cardiovasc Pharmacother, 7 (5), 453-459
    DOI 10.1093/ehjcvp/pvaa126, PubMed 33135079
  163. Szarek M, Bittner VA, Aylward P, Baccara-Dinet M, Bhatt DL, Diaz R, Fras Z, Goodman SG, Halvorsen S, Harrington RA, Jukema JW, Moriarty PM, Pordy R, Ray KK, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG, ODYSSEY OUTCOMES Investigators (2020)
    Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
    Eur Heart J, 41 (44), 4245-4255
    DOI 10.1093/eurheartj/ehaa649, PubMed 33051646
  164. Broberg AM, Geisler J, Tuohinen S, Skytta T, Hrafnkelsdóttir ÞJ, Nielsen KM, Hedayati E, Omland T, Offersen BV, Lyon AR, Gulati G (2020)
    Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer
    Curr Heart Fail Rep, 17 (6), 397-408
    DOI 10.1007/s11897-020-00486-8, PubMed 32979150
  165. Marciniak TA, Atar D, Serebruany V (2021)
    The perils of data sharing, meta-analyses, and estimating cardiovascular risk
    Eur Heart J Cardiovasc Pharmacother, 7 (3), e55-e57
    DOI 10.1093/ehjcvp/pvaa109, PubMed 32941601
  166. El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, Niessner A, Lewis BS, Coats AJS, Savarese G (2022)
    Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing
    Eur Heart J Cardiovasc Pharmacother, 8 (2), 187-210
    DOI 10.1093/ehjcvp/pvaa108, PubMed 32941594
  167. Agewall S (2020)
    Minimizing bleeding events
    Eur Heart J Cardiovasc Pharmacother, 6 (5), 271-272
    DOI 10.1093/ehjcvp/pvaa100, PubMed 32932523
  168. Khatami M, Pope MK, Le Page S, Radic P, Schirripa V, Grundvold I, Atar D (2020)
    Cardioversion Safety - Are We Doing Enough?
    Cardiology, 145 (11), 740-745
    DOI 10.1159/000509343, PubMed 32898849
  169. Zamorano JL, Gottfridsson C, Asteggiano R, Atar D, Badimon L, Bax JJ, Cardinale D, Cardone A, Feijen EAM, Ferdinandy P, López-Fernández T, Gale CP, Maduro JH, Moslehi J, Omland T, Plana Gomez JC, Scott J, Suter TM, Minotti G (2020)
    The cancer patient and cardiology
    Eur J Heart Fail, 22 (12), 2290-2309
    DOI 10.1002/ejhf.1985, PubMed 32809231
  170. Johannessen TR, Vallersnes OM, Halvorsen S, Larstorp ACK, Mdala I, Atar D (2020)
    Pre-hospital One-Hour Troponin in a Low-Prevalence Population of Acute Coronary Syndrome: OUT-ACS study
    Open Heart, 7 (2)
    DOI 10.1136/openhrt-2020-001296, PubMed 32719074
  171. Ghanima W, Brodin E, Schultze A, Shepherd L, Lambrelli D, Ulvestad M, Ramagopalan S, Halvorsen S (2020)
    Incidence and prevalence of venous thromboembolism in Norway 2010-2017
    Thromb Res, 195, 165-168
    DOI 10.1016/j.thromres.2020.07.011, PubMed 32707359
  172. Bassand JP, Apenteng PN, Atar D, Camm AJ, Cools F, Corbalan R, Fitzmaurice DA, Fox KA, Goto S, Haas S, Hacke W, Jerjes-Sanchez C, Koretsune Y, Heuzey JL, Sawhney JP, Oh S, Stępińska J, Cate VT, Verheugt FW, Kayani G, Pieper KS, Kakkar AK, Garfield-Af Investigators FT (2020)
    GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke
    Future Cardiol, 17 (1), 19-38
    DOI 10.2217/fca-2020-0014, PubMed 32696663
  173. Birnbaum Y, Levine GN, French J, Kaski JC, Atar D, Alam M, Hasdai D, Jneid H, Uretsky BF (2020)
    Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?
    Cardiovasc Drugs Ther, 34 (6), 865-870
    DOI 10.1007/s10557-020-07039-0, PubMed 32671603
  174. Agewall S (2020)
    Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?
    Eur Heart J Cardiovasc Pharmacother, 6 (4), 201-202
    DOI 10.1093/ehjcvp/pvaa075, PubMed 32668002
  175. Pope MK, Ghanima W, Atar D (2020)
    Intensification of antithrombotic therapy for chronic atherosclerosis
    Tidsskr Nor Laegeforen, 140 (10)
    DOI 10.4045/tidsskr.20.0066, PubMed 32602309
  176. Stensjøen AL, Hommerstad A, Halvorsen S, Arheden H, Engblom H, Erlinge D, Larsen AI, Sejersten Ripa M, Clemmensen P, Atar D, Hall TS (2020)
    Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
    Ann Noninvasive Electrocardiol, 25 (6), e12784
    DOI 10.1111/anec.12784, PubMed 32592427
  177. Willeit P, Tschiderer L, Allara E, Reuber K, Seekircher L, Gao L, Liao X, Lonn E, Gerstein HC, Yusuf S, Brouwers FP, Asselbergs FW, van Gilst W, Anderssen SA, Grobbee DE, Kastelein JJP, Visseren FLJ, Ntaios G, Hatzitolios AI, Savopoulos C, Nieuwkerk PT, Stroes E, Walters M, Higgins P, Dawson J et al. (2020)
    Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
    Circulation, 142 (7), 621-642
    DOI 10.1161/CIRCULATIONAHA.120.046361, PubMed 32546049
  178. Ødegaard KM, Hallén J, Lirhus SS, Melberg HO, Halvorsen S (2020)
    Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016
    ESC Heart Fail, 7 (4), 1917-1926
    DOI 10.1002/ehf2.12773, PubMed 32530563
  179. Agewall S (2018)
    Adherence to guidelines, compliance to treatment, and treatment quality
    Eur Heart J Cardiovasc Pharmacother, 4 (4), 189-190
    DOI 10.1093/ehjcvp/pvy033, PubMed 32420591
  180. Bogsrud MP, Øyri LKL, Halvorsen S, Atar D, Leren TP, Holven KB (2020)
    Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction
    J Clin Lipidol, 14 (3), 339-345
    DOI 10.1016/j.jacl.2020.04.002, PubMed 32418822
  181. Agewall S (2020)
    Focus on subpopulations of atrial fibrillation patients
    Eur Heart J Cardiovasc Pharmacother, 6 (3), 131-132
    DOI 10.1093/ehjcvp/pvaa034, PubMed 32412082
  182. Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Mauri Ferré J, Windecker S, Dudek D, Baumbach A (2020)
    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
    Eur Heart J, 41 (19), 1839-1851
    DOI 10.1093/eurheartj/ehaa381, PubMed 32405641
  183. Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Ferré JM, Windecker S, Dudek D, Baumbach A (2020)
    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
    EuroIntervention, 16 (3), 233-246
    DOI 10.4244/EIJY20M05_01, PubMed 32404302
  184. Butt N, Bache-Mathiesen LK, Ushakova A, Nordrehaug JE, Jensen SE, Munk PS, Danchin N, Dubois-Rande JL, Hansen HS, Paganelli F, Corvoisier PL, Firat H, Erlinge D, Atar D, Larsen AI (2020)
    Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size
    Eur Heart J Acute Cardiovasc Care, 9 (4), 302-312
    DOI 10.1177/2048872620923641, PubMed 32403934
  185. Täger T, Atar D, Agewall S, Katus HA, Grundtvig M, Cleland JGF, Clark AL, Fröhlich H, Frankenstein L (2021)
    Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
    Heart Fail Rev, 26 (6), 1421-1435
    DOI 10.1007/s10741-020-09954-8, PubMed 32314085
  186. Kjeldsen SE, Halvorsen S, Wyller TB, Bath PM, Sandercock P (2020)
    Eivind Berge, MD, PhD, 1964-2020: Cardiologist Who Was Fighting Stroke
    Stroke, 51 (5), 1353-1355
    DOI 10.1161/STROKEAHA.120.029351, PubMed 32200755
  187. Langseth MS, Helseth R, Ritschel V, Hansen CH, Andersen GØ, Eritsland J, Halvorsen S, Fagerland MW, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2020)
    Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
    Sci Rep, 10 (1), 5007
    DOI 10.1038/s41598-020-61971-7, PubMed 32193509
  188. Jortveit J, Halvorsen S, Langørgen J (2020)
    Pharmacy-dispensed drugs for secondary prevention after myocardial infarction
    Tidsskr Nor Laegeforen, 140 (4)
    DOI 10.4045/tidsskr.19.0416, PubMed 32192264
  189. Agewall S (2020)
    Lipids and antithrombotic treatment
    Eur Heart J Cardiovasc Pharmacother, 6 (2), 71
    DOI 10.1093/ehjcvp/pvaa014, PubMed 32176294
  190. Jortveit J, Pripp AH, Langørgen J, Halvorsen S (2020)
    Incidence, risk factors and outcome of young patients with myocardial infarction
    Heart, 106 (18), 1420-1426
    DOI 10.1136/heartjnl-2019-316067, PubMed 32111640
  191. Gorog DA, Price S, Sibbing D, Baumbach A, Capodanno D, Gigante B, Halvorsen S, Huber K, Lettino M, Leonardi S, Morais J, Rubboli A, Siller-Matula JM, Storey RF, Vranckx P, Rocca B (2021)
    Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Eur Heart J Cardiovasc Pharmacother, 7 (2), 125-140
    DOI 10.1093/ehjcvp/pvaa009, PubMed 32049278
  192. Tancin Lambert A, Kong XY, Ratajczak-Tretel B, Atar D, Russell D, Skjelland M, Bjerkeli V, Skagen K, Coq M, Schordan E, Firat H, Halvorsen B, Aamodt AH (2020)
    Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study
    Cerebrovasc Dis Extra, 10 (1), 11-20
    DOI 10.1159/000504529, PubMed 32028277
  193. Gorenek B, Halvorsen S, Kudaiberdieva G, Bueno H, Van Gelder IC, Lettino M, Marin F, Masip J, Mueller C, Okutucu S, Poess J, Potpara TS, Price S, Lip GYH (2020)
    Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology
    Eur Heart J Acute Cardiovasc Care, 9 (4), 348-357
    DOI 10.1177/2048872619894255, PubMed 31976747
  194. Stepinska J, Lettino M, Ahrens I, Bueno H, Garcia-Castrillo L, Khoury A, Lancellotti P, Mueller C, Muenzel T, Oleksiak A, Petrino R, Guimenez MR, Zahger D, Vrints CJ, Halvorsen S, de Maria E, Lip GY, Rossini R, Claeys M, Huber K (2020)
    Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
    Eur Heart J Acute Cardiovasc Care, 9 (1), 76-89
    DOI 10.1177/2048872619885346, PubMed 31958018
  195. Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, Fras Z, Goodman SG, Halvorsen S, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Moriarty PM, Moryusef A, Pordy R, Roe MT, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG et al. (2020)
    Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
    J Am Coll Cardiol, 75 (2), 133-144
    DOI 10.1016/j.jacc.2019.10.057, PubMed 31948641
  196. Rutherford OW, Jonasson C, Ghanima W, Söderdahl F, Halvorsen S (2020)
    Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
    Eur Heart J Cardiovasc Pharmacother, 6 (2), 75-85
    DOI 10.1093/ehjcvp/pvz086, PubMed 31942972
  197. Aamodt IT, Lycholip E, Celutkiene J, von Lueder T, Atar D, Falk RS, Hellesø R, Jaarsma T, Strömberg A, Lie I (2020)
    Self-Care Monitoring of Heart Failure Symptoms and Lung Impedance at Home Following Hospital Discharge: Longitudinal Study
    J Med Internet Res, 22 (1), e15445
    DOI 10.2196/15445, PubMed 31909717
  198. Agewall S (2020)
    Focus on pharma in acute coronary syndrome
    Eur Heart J Cardiovasc Pharmacother, 6 (1), 1-2
    DOI 10.1093/ehjcvp/pvz074, PubMed 31909430
  199. Garcia DA, Fisher DA, Mulder H, Wruck L, De Caterina R, Halvorsen S, Granger CB, Held C, Wallentin L, Alexander JH, Lopes RD (2019)
    Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Am Heart J, 221, 1-8
    DOI 10.1016/j.ahj.2019.10.013, PubMed 31896036
  200. Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M et al. (2019)
    Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
    Atherosclerosis, 296, 74-82
    DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625
  201. Helseth R, Shetelig C, Andersen GØ, Langseth MS, Limalanathan S, Opstad TB, Arnesen H, Hoffmann P, Eritsland J, Seljeflot I (2019)
    Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
    Mediators Inflamm, 2019, 7816491
    DOI 10.1155/2019/7816491, PubMed 31772506
  202. Atar D, Berge E, Le Heuzey JY, Virdone S, Camm AJ, Steffel J, Gibbs H, Goldhaber SZ, Goto S, Kayani G, Misselwitz F, Stepinska J, Turpie AGG, Bassand JP, Kakkar AK, GARFIELD-AF Investigators (2020)
    The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
    Europace, 22 (2), 195-204
    DOI 10.1093/europace/euz292, PubMed 31747004
  203. Bjørnnes AK, Moons P, Parry M, Halvorsen S, Tønnessen T, Lie I (2019)
    Experiences of informal caregivers after cardiac surgery: a systematic integrated review of qualitative and quantitative studies
    BMJ Open, 9 (11), e032751
    DOI 10.1136/bmjopen-2019-032751, PubMed 31719093
  204. Bhatt AS, Luo N, Solomon N, Pagidipati NJ, Ambrosio G, Green JB, McGuire DK, Standl E, Cornel JH, Halvorsen S, Lopes RD, White HD, Holman RR, Peterson ED, Mentz RJ, TECOS Study Group (2019)
    International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS
    Am Heart J, 218, 57-65
    DOI 10.1016/j.ahj.2019.08.016, PubMed 31707329
  205. Kvakkestad KM, Gran JM, Eritsland J, Holst Hansen C, Fossum E, Andersen GØ, Halvorsen S (2019)
    Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study
    Cardiology, 144 (3-4), 79-89
    DOI 10.1159/000503442, PubMed 31689705
  206. Gelbenegger G, Postula M, Pecen L, Halvorsen S, Lesiak M, Schoergenhofer C, Jilma B, Hengstenberg C, Siller-Matula JM (2019)
    Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
    BMC Med, 17 (1), 198
    DOI 10.1186/s12916-019-1428-0, PubMed 31679516
  207. Bahls M, Lorenz MW, Dörr M, Gao L, Kitagawa K, Tuomainen TP, Agewall S, Berenson G, Catapano AL, Norata GD, Bots ML, van Gilst W, Asselbergs FW, Brouwers FP, Uthoff H, Sander D, Poppert H, Hecht Olsen M, Empana JP, Schminke U, Baldassarre D, Veglia F, Franco OH, Kavousi M, de Groot E et al. (2019)
    Progression of conventional cardiovascular risk factors and vascular disease risk in individuals: insights from the PROG-IMT consortium
    Eur J Prev Cardiol, 27 (3), 234-243
    DOI 10.1177/2047487319877078, PubMed 31619084
  208. Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J et al. (2019)
    Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
    Circulation, 140 (23), 1921-1932
    DOI 10.1161/CIRCULATIONAHA.119.043308, PubMed 31557056
  209. Agewall S (2019)
    European Heart Journal - Cardiovascular Pharmacotherapy has received its first Impact Factor of 6.723
    Eur Heart J Cardiovasc Pharmacother, 5 (4), 183-184
    DOI 10.1093/ehjcvp/pvz041, PubMed 31531677
  210. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ et al. (2020)
    2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
    Eur Heart J, 41 (3), 407-477
    DOI 10.1093/eurheartj/ehz425, PubMed 31504439
  211. Marciniak TA, Atar D, Serebruany V (2019)
    Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients?
    Am J Med, 133 (3), 347-351
    DOI 10.1016/j.amjmed.2019.07.046, PubMed 31442391
  212. Allencherril J, Jneid H, Atar D, Alam M, Levine G, Kloner RA, Birnbaum Y (2019)
    Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon
    Cardiovasc Drugs Ther, 33 (5), 589-597
    DOI 10.1007/s10557-019-06901-0, PubMed 31418141
  213. Hollan I, Ronda N, Dessein P, Agewall S, Karpouzas G, Tamargo J, Niessner A, Savarese G, Rosano G, Kaski JC, Wassmann S, Meroni PL (2020)
    Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
    Eur Heart J Cardiovasc Pharmacother, 6 (2), 104-114
    DOI 10.1093/ehjcvp/pvz033, PubMed 31397840
  214. Savarese G, Reiner MF, Uijl A, D'Amario D, Agewall S, Atar D, Baumgartner I, Borghi C, De Carlo M, Drexel H, Kaski JC, Kjeldsen KP, Kucher N, Lund LH, Niessner A, Semb AG, Schmidt TA, Sulzgruber P, Tamargo J, Vitale C, Wassmann S, Aboyans V, Lewis BS (2020)
    Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
    Eur Heart J Cardiovasc Pharmacother, 6 (2), 86-93
    DOI 10.1093/ehjcvp/pvz036, PubMed 31392312
  215. Al-Ani A, Hoffmann P, von Lueder T, Opdahl A (2019)
    Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation
    Catheter Cardiovasc Interv, 95 (6), 1171-1175
    DOI 10.1002/ccd.28419, PubMed 31379116
  216. Frankenstein L, Seide S, Täger T, Jensen K, Fröhlich H, Clark AL, Seiz M, Katus HA, Nee P, Uhlmann L, Naci H, Atar D (2020)
    Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials
    Heart Fail Rev, 25 (2), 161-171
    DOI 10.1007/s10741-019-09832-y, PubMed 31364027
  217. Fox KAA, Metra M, Morais J, Atar D (2019)
    The myth of 'stable' coronary artery disease
    Nat Rev Cardiol, 17 (1), 9-21
    DOI 10.1038/s41569-019-0233-y, PubMed 31358978
  218. Marti HP, Serebruany V, Atar D (2019)
    Challenging Anticoagulation in Advanced Renal Failure
    Am J Med, 132 (11), 1258-1259
    DOI 10.1016/j.amjmed.2019.07.002, PubMed 31356767
  219. Hokstad I, Deyab G, Wang Fagerland M, Lyberg T, Hjeltnes G, Førre Ø, Agewall S, Mollnes TE, Hollan I (2019)
    Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
    PLoS One, 14 (7), e0220079
    DOI 10.1371/journal.pone.0220079, PubMed 31335881
  220. Ahrens I, Averkov O, Zúñiga EC, Fong AYY, Alhabib KF, Halvorsen S, Abdul Kader MABSK, Sanz-Ruiz R, Welsh R, Yan H, Aylward P (2019)
    Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox
    Clin Cardiol, 42 (10), 1028-1040
    DOI 10.1002/clc.23232, PubMed 31317575
  221. Verheugt FWA, Ambrosio G, Atar D, Bassand JP, Camm AJ, Costabel JP, Fitzmaurice DA, Illingworth L, Goldhaber SZ, Goto S, Haas S, Jansky P, Kayani G, Stepinska J, Turpie AGG, van Eickels M, Kakkar AK, GARFIELD-AF Investigators (2019)
    Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF
    Am J Med, 132 (12), 1431-1440.e7
    DOI 10.1016/j.amjmed.2019.06.008, PubMed 31306621
  222. Pradhan B, Kjellstrom T, Atar D, Sharma P, Kayastha B, Bhandari G, Pradhan PK (2019)
    Heat Stress Impacts on Cardiac Mortality in Nepali Migrant Workers in Qatar
    Cardiology, 143 (1), 37-48
    DOI 10.1159/000500853, PubMed 31302648
  223. Drexel H, Rosano GMC, Lewis BS, Huber K, Vonbank A, Dopheide JF, Mader A, Niessner A, Savarese G, Wassmann S, Agewall S (2020)
    The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
    Eur Heart J Cardiovasc Pharmacother, 6 (2), 97-103
    DOI 10.1093/ehjcvp/pvz029, PubMed 31298686
  224. Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Solomon SD, Dickstein K, Atar D, Agewall S, Girerd N, High-Risk Myocardial Infarction Database Initiative investigators (2019)
    Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction
    Am Heart J, 215, 83-90
    DOI 10.1016/j.ahj.2019.06.004, PubMed 31291604
  225. Nordlund D, Engblom H, Bonnet JL, Hansen HS, Atar D, Erlinge D, Ekelund U, Heiberg E, Carlsson M, Arheden H (2019)
    Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients - data from the CHILL-MI, MITOCARE and SOCCER trials
    BMC Cardiovasc Disord, 19 (1), 161
    DOI 10.1186/s12872-019-1139-7, PubMed 31269907
  226. Ratajczak-Tretel B, Lambert AT, Johansen H, Halvorsen B, Bjerkeli V, Russell D, Sandset EC, Ihle-Hansen H, Eriksen E, Næss H, Novotny V, Khanevski AN, Truelsen TC, Idicula T, Ægidius KL, Tobro H, Krogseth SB, Ihle-Hansen H, Hagberg G, Kruuse C, Arntzen K, Bakkejord GK, Villseth M, Nakstad I, Eldøen G et al. (2019)
    Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design
    Eur Stroke J, 4 (2), 172-180
    DOI 10.1177/2396987319837089, PubMed 31259265
  227. Agewall S (2019)
    Antiplatelet treatment in acute coronary syndrome. Still an issue
    Eur Heart J Cardiovasc Pharmacother, 5 (3), 125-126
    DOI 10.1093/ehjcvp/pvz018, PubMed 31210265
  228. Fossum S, Næss Ø, Halvorsen S, Tell GS, Vikanes ÅV (2019)
    Long-term cardiovascular morbidity following hyperemesis gravidarum: A Norwegian nationwide cohort study
    PLoS One, 14 (6), e0218051
    DOI 10.1371/journal.pone.0218051, PubMed 31188868
  229. Gerdts E, Saeed S, Midtbø H, Rossebø A, Chambers JB, Einarsen E, Bahlmann E, Devereux R (2019)
    Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis
    Heart, 105 (21), 1629-1633
    DOI 10.1136/heartjnl-2018-314462, PubMed 31154431
  230. von Lueder TG, Atar D, Agewall S, Jensen JK, Hopper I, Kotecha D, Mentz RJ, Kim MH, Serebruany VL (2019)
    All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
    Am J Ther, 26 (6), e671-e678
    DOI 10.1097/MJT.0000000000000883, PubMed 31145139
  231. Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A (2019)
    Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
    Eur Heart J Cardiovasc Pharmacother, 5 (3), 171-180
    DOI 10.1093/ehjcvp/pvz016, PubMed 31119266
  232. Fernandes A, McEvoy JW, Halvorsen S (2019)
    "Doctor, Should I Keep Taking an Aspirin a Day?"
    N Engl J Med, 380 (20), 1967-1970
    DOI 10.1056/NEJMclde1903004, PubMed 31091380
  233. Hjort M, Eggers KM, Lindhagen L, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Malmqvist K, Spaak J, Sörensson P, Y-Hassan S, Tornvall P, Lindahl B (2019)
    Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries
    Clin Chem, 65 (8), 1023-1030
    DOI 10.1373/clinchem.2018.301085, PubMed 31072836
  234. Hausvater A, Pasupathy S, Tornvall P, Gandhi H, Tavella R, Beltrame J, Agewall S, Ekenbäck C, Brolin EB, Hochman JS, Collste O, Reynolds HR (2019)
    ST-segment elevation and cardiac magnetic resonance imaging findings in myocardial infarction with non-obstructive coronary arteries
    Int J Cardiol, 287, 128-131
    DOI 10.1016/j.ijcard.2019.04.028, PubMed 31003795
  235. Jortveit J, Pripp AH, Langørgen J, Halvorsen S (2019)
    Poor adherence to guideline recommendations among patients with atrial fibrillation and acute myocardial infarction
    Eur J Prev Cardiol, 26 (13), 1373-1382
    DOI 10.1177/2047487319841940, PubMed 30966816
  236. Kotecha D, Flather MD, Atar D, Collins P, Pepper J, Jenkins E, Reid CM, Eccleston D, Alternative Risk Markers in Coronary Artery Disease (ARM-CAD) Study (2019)
    B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease
    BMC Med, 17 (1), 72
    DOI 10.1186/s12916-019-1306-9, PubMed 30943979
  237. Hoffmann P, Al-Ani A, von Lueder T, Skoe ØW, Tran TT, Opdahl A (2018)
    Late Pseudoaneurysm After Access Site Closure with Manta in Transfemoral Aortic Valve Implantation
    EJVES Short Rep, 42, 34-36
    DOI 10.1016/j.ejvssr.2018.10.003, PubMed 30931405
  238. Jortveit J, Halvorsen S, Kaldal A, Pripp AH, Govatsmark RES, Langørgen J (2019)
    Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease
    BMC Cardiovasc Disord, 19 (1), 71
    DOI 10.1186/s12872-019-1062-y, PubMed 30922234
  239. Agewall S (2019)
    European Heart Journal - Cardiovascular Pharmacotherapy: now accepted for an official Impact Factor
    Eur Heart J Cardiovasc Pharmacother, 5 (2), 59
    DOI 10.1093/ehjcvp/pvz009, PubMed 30874813
  240. Agewall S (2019)
    Unsolved issues in oral anticoagulation treatment in atrial fibrillation
    Eur Heart J Cardiovasc Pharmacother, 5 (2), 60-61
    DOI 10.1093/ehjcvp/pvz008, PubMed 30874812
  241. Atar D (2019)
    Editor's Note
    Cardiology, 142 (1), 1
    DOI 10.1159/000497089, PubMed 30852568
  242. Rosano GMC, Spoletini I, Agewall S (2019)
    Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
    Eur Heart J Suppl, 21 (Suppl A), A28-A33
    DOI 10.1093/eurheartj/suy035, PubMed 30837802
  243. Täger T, Fröhlich H, Grundtvig M, Seiz M, Schellberg D, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L (2019)
    Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis
    Int J Cardiol, 289, 83-90
    DOI 10.1016/j.ijcard.2019.01.109, PubMed 30827731
  244. Serebruany VL, Marciniak TA, Atar D (2019)
    Predicting clinical outcomes after clopidogrel use: easier to postulate than to prove and implement
    Pol Arch Intern Med, 129 (2), 78-79
    DOI 10.20452/pamw.4467, PubMed 30816102
  245. Fröhlich H, Rosenfeld N, Täger T, Goode K, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Clark AL, Frankenstein L, Grundtvig M (2019)
    Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe
    Heart, 105 (16), 1252-1259
    DOI 10.1136/heartjnl-2018-314256, PubMed 30792238
  246. Atar D, Grundvold I (2019)
    On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient?
    Eur Heart J, 40 (19), 1501-1503
    DOI 10.1093/eurheartj/ehz014, PubMed 30753396
  247. Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
    Medical Misinformation: Vet the Message!
    J Cardiovasc Pharmacol, 73 (2), 61-62
    DOI 10.1097/FJC.0000000000000648, PubMed 30730472
  248. Aamodt IT, Lycholip E, Celutkiene J, Strömberg A, Atar D, Falk RS, von Lueder T, Hellesø R, Jaarsma T, Lie I (2019)
    Health Care Professionals' Perceptions of Home Telemonitoring in Heart Failure Care: Cross-Sectional Survey
    J Med Internet Res, 21 (2), e10362
    DOI 10.2196/10362, PubMed 30724744
  249. Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
    Medical misinformation: Vet the message!
    Heart Rhythm, 16 (3), 332-333
    DOI 10.1016/j.hrthm.2018.12.030, PubMed 30703343
  250. Kjeldsen SE, Atar D, von Lueder TG (2019)
    Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 5 (2), 122-123
    DOI 10.1093/ehjcvp/pvz005, PubMed 30698668
  251. Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
    Medical misinformation: vet the message!
    Eur Heart J Qual Care Clin Outcomes, 5 (2), 83-84
    DOI 10.1093/ehjqcco/qcy057, PubMed 30689789
  252. Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
    Medical misinformation: vet the message!
    Eur Heart J Cardiovasc Pharmacother, 5 (2), 62-63
    DOI 10.1093/ehjcvp/pvz001, PubMed 30689786
  253. Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, Gropler R, Guzik TJ, Heinemann MK, Iskandrian AE, Knight BP, London B, Lüscher TF, Metra M, Musunuru K, Nallamothu BK, Natale A, Saksena S, Picard MH, Rao SV, Remme WJ et al. (2019)
    Medical misinformation: vet the message!
    Cardiovasc Res, 115 (14), e187-8 (in press)
    DOI 10.1093/cvr/cvz007, PubMed 30689762
  254. Hoffmann P, Al-Ani A, von Lueder T, Hoffmann J, Majak P, Hagen O, Loose H, Kløw NE, Opdahl A (2018)
    Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide
    CVIR Endovasc, 1 (1), 20
    DOI 10.1186/s42155-018-0026-0, PubMed 30652151
  255. Agewall S (2019)
    Old and new drugs in cardiovascular pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 5 (1), 1-2
    DOI 10.1093/ehjcvp/pvy046, PubMed 30615170
  256. Rutherford OW, Jonasson C, Ghanima W, Holst R, Halvorsen S (2018)
    New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
    Open Heart, 5 (2), e000931
    DOI 10.1136/openhrt-2018-000931, PubMed 30613418
  257. Stubnova V, Os I, Høieggen A, Solbu MD, Grundtvig M, Westheim AS, Atar D, Waldum-Grevbo B (2019)
    Gender differences in association between uric acid and all-cause mortality in patients with chronic heart failure
    BMC Cardiovasc Disord, 19 (1), 4
    DOI 10.1186/s12872-018-0989-8, PubMed 30611196
  258. Alexander KP, Brouwer MA, Mulder H, Vinereanu D, Lopes RD, Proietti M, Al-Khatib SM, Hijazi Z, Halvorsen S, Hylek EM, Verheugt FWA, Alexander JH, Wallentin L, Granger CB, ARISTOTLE Investigators (2018)
    Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial
    Am Heart J, 208, 123-131
    DOI 10.1016/j.ahj.2018.09.017, PubMed 30579505
  259. Bugge C, Sether EM, Pahle A, Halvorsen S, Sonbo Kristiansen I (2018)
    Diagnosing heart failure with NT-proBNP point-of-care testing: lower costs and better outcomes. A decision analytic study
    BJGP Open, 2 (3), bjgpopen18X101596
    DOI 10.3399/bjgpopen18X101596, PubMed 30564729
  260. Allencherril J, Alam M, Levine G, Jneid H, Atar D, Kloner RA, Birnbaum Y (2018)
    Do We Need Potent Intravenous Antiplatelet Inhibition at the Time of Reperfusion During ST-Segment Elevation Myocardial Infarction?
    J Cardiovasc Pharmacol Ther, 24 (3), 215-224
    DOI 10.1177/1074248418812167, PubMed 30563349
  261. Tjora S, Hall TS, Larstorp AC, Hallen J, Atar D (2018)
    Increases in Circulating Cardiac Troponin Are Not Always Associated with Myocardial Cell Death
    Clin Lab, 64 (11)
    DOI 10.7754/Clin.Lab.2018.180615, PubMed 30549980
  262. Munkhaugen J, Ruddox V, Halvorsen S, Dammen T, Fagerland MW, Hernæs KH, Vethe NT, Prescott E, Jensen SE, Rødevand O, Jortveit J, Bendz B, Schirmer H, Køber L, Bøtker HE, Larsen AI, Vikenes K, Steigen T, Wiseth R, Pedersen T, Edvardsen T, Otterstad JE, Atar D (2018)
    BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study
    Am Heart J, 208, 37-46
    DOI 10.1016/j.ahj.2018.10.005, PubMed 30530121
  263. Nero D, Agewall S, Daniel M, Caidahl K, Collste O, Ekenbäck C, Frick M, Henareh L, Jernberg T, Malmqvist K, Schenck-Gustafsson K, Spaak J, Sörensson P, Sundin Ö, Y-Hassan S, Hofman-Bang C, Tornvall P (2018)
    Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries
    Am J Med, 132 (3), 374-381.e1
    DOI 10.1016/j.amjmed.2018.11.010, PubMed 30503881
  264. Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Siegbahn A, Wallentin L (2018)
    Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial
    Open Heart, 5 (2), e000908
    DOI 10.1136/openhrt-2018-000908, PubMed 30487982
  265. Bethke A, Shanmuganathan L, Shetelig C, Swanson D, Andersen GØ, Eritsland J, Kløw NE, Hoffmann P (2018)
    MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
    PLoS One, 13 (11), e0206723
    DOI 10.1371/journal.pone.0206723, PubMed 30412607
  266. Navarese EP, Andreotti F, Raggi P, Kolodziejczak M, Buffon A, Bliden K, Tantry U, Kubica J, Sardella G, Lauten A, Agewall S, Gurbel PA, Brouwer MA (2019)
    Baseline low-density lipoprotein cholesterol to predict the extent of cardiovascular benefit from lipid-lowering therapies: a review
    Eur Heart J Cardiovasc Pharmacother, 5 (1), 47-54
    DOI 10.1093/ehjcvp/pvy038, PubMed 30247574
  267. Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, Huber K, Hylek EM, Lopes RD, Oh BH, Siegbahn A (2018)
    Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
    Heart, 105 (3), 235-242
    DOI 10.1136/heartjnl-2018-313351, PubMed 30209126
  268. Serebruany VL, Hall TS, Atar D, Agewall S, Hyun Kim M, Geudelin B, Lomakin N, Marciniak TA (2019)
    Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System
    Eur Heart J Cardiovasc Pharmacother, 5 (4), 210-215
    DOI 10.1093/ehjcvp/pvy035, PubMed 30192939
  269. Dahl Aarvik M, Sandven I, Dondo TB, Gale CP, Ruddox V, Munkhaugen J, Atar D, Otterstad JE (2019)
    Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
    Eur Heart J Cardiovasc Pharmacother, 5 (1), 12-20
    DOI 10.1093/ehjcvp/pvy034, PubMed 30192930
  270. Hall TS, von Lueder TG, Zannad F, Rossignol P, Duarte K, Chouihed T, Dickstein K, Atar D, Agewall S, Girerd N, High-Risk Myocardial Infarction Database Initiative investigators (2018)
    Relationship between left ventricular ejection fraction and mortality after myocardial infarction complicated by heart failure or left ventricular dysfunction
    Int J Cardiol, 272, 260-266
    DOI 10.1016/j.ijcard.2018.07.137, PubMed 30144995
  271. Niessner A, Agewall S (2018)
    Critical appraisal of the COMPASS trial
    Eur Heart J Cardiovasc Pharmacother, 4 (4), 191-192
    DOI 10.1093/ehjcvp/pvy027, PubMed 30113628
  272. Vonbank A, Drexel H, Agewall S, Lewis BS, Dopheide JF, Kjeldsen K, Ceconi C, Savarese G, Rosano G, Wassmann S, Niessner A, Schmidt TA, Saely CH, Baumgartner I, Tamargo J (2018)
    Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a review
    Eur Heart J Cardiovasc Pharmacother, 4 (4), 230-236
    DOI 10.1093/ehjcvp/pvy028, PubMed 30099530
  273. Jia X, Heiberg E, Sejersten Ripa M, Engblom H, Carlsson M, Halvorsen S, Arheden H, Atar D, Clemmensen P, Birnbaum Y (2018)
    Cardiac Magnetic Resonance Evaluation of the Extent of Myocardial Injury in Patients with Inferior ST Elevation Myocardial Infarction and Concomitant ST Depression in Leads V1-V3: Analysis from the MITOCARE Study
    Cardiology, 140 (3), 178-185
    DOI 10.1159/000491745, PubMed 30099440
  274. Berwanger O, Abdelhamid M, Alexander T, Alzubaidi A, Averkov O, Aylward P, Contreras Zúñiga E, Halvorsen S, Iglesias R, A Sk Abdul Kader M, Zubaid M, AlHabib KF (2018)
    Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study
    Clin Cardiol, 41 (10), 1322-1327
    DOI 10.1002/clc.23043, PubMed 30098028
  275. Ruddox V, Otterstad JE, Atar D, Bendz B, Edvardsen T (2018)
    In Current Clinical Practice, after Percutaneous Coronary Intervention for Acute Myocardial Infarction, Are β-Blockers Prescribed for Heart Failure or as Secondary Prevention? A Pilot Study
    Cardiology, 140 (3), 152-154
    DOI 10.1159/000490656, PubMed 30089282
  276. Mayerhofer CCK, Awoyemi AO, Moscavitch SD, Lappegård KT, Hov JR, Aukrust P, Hovland A, Lorenzo A, Halvorsen S, Seljeflot I, Gullestad L, Trøseid M, Broch K (2018)
    Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
    ESC Heart Fail, 5 (5), 977-984
    DOI 10.1002/ehf2.12332, PubMed 30088346
  277. Lip GYH, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin F, Obel I, Rubboli A, Storey RF, Valgimigli M, Huber K, ESC Scientific Document Group (2019)
    2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)
    Europace, 21 (2), 192-193
    DOI 10.1093/europace/euy174, PubMed 30052888
  278. Agewall S (2018)
    New input on antiplatelet treatment and registry studies
    Eur Heart J Cardiovasc Pharmacother, 4 (3), 129-130
    DOI 10.1093/ehjcvp/pvy016, PubMed 30052852
  279. Lewis BS, Atar D (2018)
    Peripheral arterial disease and limb salvage: a new arena for the cardiologist
    Eur Heart J Cardiovasc Pharmacother, 4 (3), 136-137
    DOI 10.1093/ehjcvp/pvy014, PubMed 30052851
  280. Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
    Author's response to: letter to the editor
    Heart Fail Rev, 23 (5), 819
    DOI 10.1007/s10741-018-9728-6, PubMed 30043131
  281. von Lueder TG, Agewall S (2018)
    The burden of heart failure in the general population: a clearer and more concerning picture
    J Thorac Dis, 10 (Suppl 17), S1934-S1937
    DOI 10.21037/jtd.2018.04.153, PubMed 30023084
  282. Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y (2018)
    Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging
    J Electrocardiol, 51 (4), 563-568
    DOI 10.1016/j.jelectrocard.2018.03.016, PubMed 29996989
  283. Bethke A, Shanmuganathan L, Andersen GØ, Eritsland J, Swanson D, Kløw NE, Hoffmann P (2018)
    Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
    Eur Radiol, 29 (2), 941-950
    DOI 10.1007/s00330-018-5588-7, PubMed 29980929
  284. Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
    Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
    J Am Coll Cardiol, 72 (2), 187-198
    DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293
  285. Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Ripa MS, Birnbaum Y (2018)
    The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging
    Ann Noninvasive Electrocardiol, 23 (6), e12580
    DOI 10.1111/anec.12580, PubMed 29971868
  286. Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
    Response to the editor
    Heart Fail Rev (in press)
    DOI 10.1007/s10741-018-9723-y, PubMed 29968222
  287. Fossum S, Halvorsen S, Vikanes ÅV, Roseboom TJ, Ariansen I, Næss Ø (2018)
    Cardiovascular risk profile at the age of 40-45 in women with previous hyperemesis gravidarum or hypertensive disorders in pregnancy: A population-based study
    Pregnancy Hypertens, 12, 129-135
    DOI 10.1016/j.preghy.2018.04.013, PubMed 29858105
  288. Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
    Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
    Int J Cardiol, 268, 187-192
    DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279
  289. Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, Ceconi C, Coats AJS, Drexel H, Filippatos G, Kaski JC, Lund L, Niessner A, Ponikowski P, Savarese G, Schmidt TA, Seferovic P, Wassmann S, Walther T, Lewis BS (2018)
    Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
    Eur Heart J Cardiovasc Pharmacother, 4 (3), 180-188
    DOI 10.1093/ehjcvp/pvy015, PubMed 29726985
  290. Pahlm U, Seemann F, Engblom H, Gyllenhammar T, Halvorsen S, Hansen HS, Erlinge D, Atar D, Heiberg E, Arheden H, Carlsson M (2018)
    Longitudinal left ventricular function is globally depressed within a week of STEMI
    Clin Physiol Funct Imaging, 38 (6), 1029-1037
    DOI 10.1111/cpf.12521, PubMed 29701310
  291. Hansen CH, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Seljeflot I (2018)
    Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
    Clin Appl Thromb Hemost, 24 (7), 1088-1094
    DOI 10.1177/1076029618764847, PubMed 29695176
  292. Aboyans V, Björck M, Brodmann M, Collet JP, Czerny M, De Carlo M, Naylor AR, Roffi M, Tendera M, Vlachopoulos C, Ricco JB, Task Force for the 2017 ESC Guidelines for the diagnosis and management of Peripheral Arterial Diseases, in collaboration with the ESVS, Document Reviewers, Widimsky P, Kolh P, Dick F, Vega de Ceniga M, Piepoli MF, Sievert H, Sulzenko J, Esc Committee For Practice Guidelines Cpg, Windecker S, Aboyans V, Agewall S, Barbato E et al. (2018)
    Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
    Eur J Vasc Endovasc Surg, 55 (4), 457-464
    DOI 10.1016/j.ejvs.2017.08.014, PubMed 29628287
  293. Jia X, Heiberg E, Ripa MS, Engblom H, Halvorsen S, Arheden H, Atar D, Clemmensen P, Birnbaum Y (2018)
    Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMI
    Scand Cardiovasc J, 52 (4), 189-195
    DOI 10.1080/14017431.2018.1458145, PubMed 29595340
  294. Andresen K, Atar D, Gjertsen E, Ghanima W, Roseth S, Johansen OE (2018)
    Mechanisms of action and clinical use of specific reversal agents for non-vitamin K antagonist oral anticoagulants
    Scand Cardiovasc J, 52 (3), 156-162
    DOI 10.1080/14017431.2018.1453613, PubMed 29569500
  295. Agewall S (2018)
    Cardiovascular pharmacotherapy and real-world data
    Eur Heart J Cardiovasc Pharmacother, 4 (2), 65-66
    DOI 10.1093/ehjcvp/pvy008, PubMed 29554294
  296. Bonaca MP, De Ferrari GM, Atar D, Bash LD, Lautsch D, Bohula EA, Horack M, Brudi P, Ferrieres J, Gitt AK (2018)
    How does the TRS 2°P score relate to real-world patients?
    Eur Heart J Cardiovasc Pharmacother, 4 (2), 72-74
    DOI 10.1093/ehjcvp/pvy004, PubMed 29554293
  297. Ofstad AP, Atar D, Gullestad L, Langslet G, Johansen OE (2018)
    The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions
    Heart Fail Rev, 23 (3), 303-323
    DOI 10.1007/s10741-018-9685-0, PubMed 29516230
  298. Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF (2018)
    Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
    Eur Heart J, 39 (19), 1672-1686f
    DOI 10.1093/eurheartj/ehy066, PubMed 29509886
  299. Wisløff T, Atar D (2016)
    Cost-effectiveness of antiplatelet drugs after percutaneous coronary intervention
    Eur Heart J Qual Care Clin Outcomes, 2 (1), 52-57
    DOI 10.1093/ehjqcco/qcv023, PubMed 29474586
  300. Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH (2017)
    Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial
    Am Heart J, 197, 133-141
    DOI 10.1016/j.ahj.2017.11.005, PubMed 29447773
  301. Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Gorenek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumura K, Piccini JP, Potpara T, Poulsen BK, Saba M, Savelieva I, Tamargo JL, Wolpert C, ESC Scientific Document Group (2018)
    Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
    Europace, 20 (5), 731-732an
    DOI 10.1093/europace/eux373, PubMed 29438514
  302. Pol T, Held C, Westerbergh J, Lindbäck J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z (2018)
    Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial
    J Am Heart Assoc, 7 (3)
    DOI 10.1161/JAHA.117.007444, PubMed 29419390
  303. Agewall S (2018)
    Cardiovascular pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 4 (1), 1
    DOI 10.1093/ehjcvp/pvx036, PubMed 29315398
  304. Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H, Casadei B, Castellá M, Chua W, Crijns H, Dobrev D, Fabritz L, Feuring M, Freedman B, Gerth A et al. (2018)
    Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
    Europace, 20 (3), 395-407
    DOI 10.1093/europace/eux318, PubMed 29300976
  305. Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D, Bassand JP, Camm AJ, Cools F, Eikelboom J, Kayani G, Lim TW, Misselwitz F, Pieper KS, van Eickels M, Kakkar AK, GARFIELD-AF Investigators (2018)
    Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry
    Eur Heart J, 39 (6), 464-473
    DOI 10.1093/eurheartj/ehx730, PubMed 29281086
  306. Kaluzna-Oleksy M, Aunan K, Rao-Skirbekk S, Kjellstrom T, Ezekowitz JA, Agewall S, Atar D (2017)
    Impact of climate and air pollution on acute coronary syndromes: an update from the European Society of Cardiology Congress 2017
    Scand Cardiovasc J, 52 (1), 1-3
    DOI 10.1080/14017431.2017.1405069, PubMed 29202608
  307. Ibánez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P (2017)
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    Rev Esp Cardiol (Engl Ed), 70 (12), 1082
    DOI 10.1016/j.rec.2017.11.010, PubMed 29198432
  308. Atar D, Hanssen KF (2017)
    Type 2 Diabetes and Heart Failure - More Scrutiny Wanted!
    Cardiology, 139 (1), 37-39
    DOI 10.1159/000484345, PubMed 29186706
  309. Bang CN, Greve AM, Rossebø AB, Ray S, Egstrup K, Boman K, Nienaber C, Okin PM, Devereux RB, Wachtell K (2017)
    Antihypertensive Treatment With β-Blockade in Patients With Asymptomatic Aortic Stenosis and Association With Cardiovascular Events
    J Am Heart Assoc, 6 (12)
    DOI 10.1161/JAHA.117.006709, PubMed 29180457
  310. Agewall S (2017)
    European Heart Journal - Cardiovascular Pharmacotherapy: A fast growing baby-filling an important gap in the literature
    Eur Heart J, 38 (44), 3251
    DOI 10.1093/eurheartj/ehx619, PubMed 29177414
  311. Fakhri Y, Sejersten M, Schoos MM, Hansen HS, Dubois-Rande JL, Hall TS, Larsen AI, Jensen SE, Engblom H, Arheden H, Kastrup J, Atar D, Clemmensen P (2017)
    Electrocardiographic scores of severity and acuteness of myocardial ischemia predict myocardial salvage in patients with anterior ST-segment elevation myocardial infarction
    J Electrocardiol, 51 (2), 195-202
    DOI 10.1016/j.jelectrocard.2017.11.002, PubMed 29174706
  312. Kvakkestad KM, Sandvik L, Andersen GØ, Sunde K, Halvorsen S (2017)
    Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: A prospective cohort study
    Resuscitation, 122, 41-47
    DOI 10.1016/j.resuscitation.2017.11.047, PubMed 29155294
  313. Opstad TB, Seljeflot I, Bøhmer E, Arnesen H, Halvorsen S (2017)
    MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
    Cardiology, 139 (1), 17-24
    DOI 10.1159/000481684, PubMed 29141241
  314. Russo JJ, Goodman SG, Cantor WJ, Ko DT, Bagai A, Tan MK, Di Mario C, Halvorsen S, Le May M, Fernandez-Avilés F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sanchez PL, Yan AT (2017)
    Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
    Am Heart J, 193, 46-54
    DOI 10.1016/j.ahj.2017.07.015, PubMed 29129254
  315. Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, Lewis BS (2018)
    Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J, 39 (24), 2274-2281
    DOI 10.1093/eurheartj/ehx625, PubMed 29126266
  316. Graham I, Filippatos G, Atar D, Vardas PE, Pinto FJ, Fitzsimons D (2017)
    Patient engagement
    Eur Heart J, 38 (42), 3114-3115
    DOI 10.1093/eurheartj/ehx600, PubMed 29121227
  317. Gulati G, Heck SL, Røsjø H, Ree AH, Hoffmann P, Hagve TA, Norseth J, Gravdehaug B, Steine K, Geisler J, Omland T (2017)
    Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
    J Am Heart Assoc, 6 (11)
    DOI 10.1161/JAHA.117.006513, PubMed 29118031
  318. Heck SL, Gulati G, Hoffmann P, von Knobelsdorff-Brenkenhoff F, Storås TH, Ree AH, Gravdehaug B, Røsjø H, Steine K, Geisler J, Schulz-Menger J, Omland T (2018)
    Effect of candesartan and metoprolol on myocardial tissue composition during anthracycline treatment: the PRADA trial
    Eur Heart J Cardiovasc Imaging, 19 (5), 544-552
    DOI 10.1093/ehjci/jex159, PubMed 29106497
  319. Allencherril J, Fakhri Y, Engblom H, Heiberg E, Carlsson M, Dubois-Rande JL, Halvorsen S, Hall TS, Larsen AI, Jensen SE, Arheden H, Atar D, Clemmensen P, Shah DJ, Cheong B, Sejersten M, Birnbaum Y (2017)
    Appropriateness of anteroseptal myocardial infarction nomenclature evaluated by late gadolinium enhancement cardiovascular magnetic resonance imaging
    J Electrocardiol, 51 (2), 218-223
    DOI 10.1016/j.jelectrocard.2017.09.013, PubMed 29103621
  320. Vinereanu D, Lopes RD, Mulder H, Gersh BJ, Hanna M, de Barros E Silva PGM, Atar D, Wallentin L, Granger CB, Alexander JH, ARISTOTLE Investigators (2017)
    Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin
    Stroke, 48 (12), 3266-3273
    DOI 10.1161/STROKEAHA.117.017574, PubMed 29089455
  321. Deyab G, Hokstad I, Whist JE, Smastuen MC, Agewall S, Lyberg T, Ronda N, Mikkelsen K, Hjeltnes G, Hollan I (2017)
    Methotrexate and anti-tumor necrosis factor treatment improves endothelial function in patients with inflammatory arthritis
    Arthritis Res Ther, 19 (1), 232
    DOI 10.1186/s13075-017-1439-1, PubMed 29041979
  322. Agewall S, Tjessem LH, Rossignol P, Zannad F, Atar D, Lamiral Z, Machu JL, Dickstein K, Kjekshus J, von Lueder TG, Girerd N, High Risk Myocardial Infarction Database Initiative investigators (2017)
    Heart rate prediction of outcome in heart failure following myocardial infarction depend on heart rhythm status an analysis from the high-risk myocardial infarction database initiative
    Int J Cardiol, 249, 274-281
    DOI 10.1016/j.ijcard.2017.09.182, PubMed 28964557
  323. Patrono C, Morais J, Baigent C, Collet JP, Fitzgerald D, Halvorsen S, Rocca B, Siegbahn A, Storey RF, Vilahur G (2017)
    Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
    J Am Coll Cardiol, 70 (14), 1760-1776
    DOI 10.1016/j.jacc.2017.08.037, PubMed 28958334
  324. Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
    Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
    Sci Rep, 7 (1), 11945
    DOI 10.1038/s41598-017-12372-w, PubMed 28931920
  325. Sejersten M, Fakhri Y, Pape M, Jensen SE, Heiberg E, Engblom H, Hall TS, Atar D, Clemmensen P (2017)
    Myocardium at risk assessed by electrocardiographic scores and cardiovascular magnetic resonance - a MITOCARE substudy
    J Electrocardiol, 50 (6), 725-731
    DOI 10.1016/j.jelectrocard.2017.08.019, PubMed 28918213
  326. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P, ESC Scientific Document Group (2018)
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
    Eur Heart J, 39 (2), 119-177
    DOI 10.1093/eurheartj/ehx393, PubMed 28886621
  327. Agewall S (2017)
    Morphine in acute heart failure
    J Thorac Dis, 9 (7), 1851-1854
    DOI 10.21037/jtd.2017.06.129, PubMed 28839982
  328. Campo G, Pavasini R, Morciano G, Lincoff MA, C Gibson M, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F (2017)
    Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention
    Data Brief, 14, 197-205
    DOI 10.1016/j.dib.2017.07.033, PubMed 28795098
  329. von Lueder TG, Kotecha D, Atar D, Hopper I (2017)
    Neurohormonal Blockade in Heart Failure
    Card Fail Rev, 3 (1), 19-24
    DOI 10.15420/cfr.2016:22:2, PubMed 28785471
  330. Butt N, Bache-Mathiesen LK, Nordrehaug JE, Tuseth V, Munk PS, Bonarjee V, Hall TS, Jensen SE, Halvorsen S, Firat H, Atar D, Larsen AI (2017)
    Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins
    Cardiology, 138 (2), 122-132
    DOI 10.1159/000475460, PubMed 28651249
  331. Campo G, Pavasini R, Morciano G, Lincoff AM, Gibson CM, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F (2017)
    Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials
    Int J Cardiol, 244, 59-66
    DOI 10.1016/j.ijcard.2017.06.040, PubMed 28634037
  332. Pagidipati NJ, Navar AM, Pieper KS, Green JB, Bethel MA, Armstrong PW, Josse RG, McGuire DK, Lokhnygina Y, Cornel JH, Halvorsen S, Strandberg TE, Delibasi T, Holman RR, Peterson ED, TECOS Study Group (2017)
    Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)
    Circulation, 136 (13), 1193-1203
    DOI 10.1161/CIRCULATIONAHA.117.027252, PubMed 28626088
  333. Stubnova V, Os I, Grundtvig M, Atar D, Waldum-Grevbo B (2017)
    Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study
    Cardiorenal Med, 7 (2), 128-136
    DOI 10.1159/000454933, PubMed 28611786
  334. Shavadia J, Welsh R, Gershlick A, Zheng Y, Huber K, Halvorsen S, Steg PG, Van de Werf F, Armstrong PW (2016)
    Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study
    J Am Heart Assoc, 5 (6)
    DOI 10.1161/JAHA.116.003559, PubMed 28525886
  335. Fröhlich H, Henning F, Täger T, Schellberg D, Grundtvig M, Goode K, Corletto A, Kazmi S, Hole T, Katus HA, Atar D, Cleland JGF, Agewall S, Frankenstein L, Clark AL (2018)
    Comparative effectiveness of enalapril, lisinopril, and ramipril in the treatment of patients with chronic heart failure: a propensity score-matched cohort study
    Eur Heart J Cardiovasc Pharmacother, 4 (2), 82-92
    DOI 10.1093/ehjcvp/pvx013, PubMed 28475676
  336. Lønnebakken MT, De Simone G, Saeed S, Boman K, Rossebø AB, Bahlmann E, Gohlke-Bärwolf C, Gerdts E (2017)
    Impact of stroke volume on cardiovascular risk during progression of aortic valve stenosis
    Heart, 103 (18), 1443-1448
    DOI 10.1136/heartjnl-2016-310917, PubMed 28455295
  337. Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L (2017)
    Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure
    Clin Res Cardiol, 106 (9), 711-721
    DOI 10.1007/s00392-017-1115-0, PubMed 28434020
  338. Lorenz MW, Abdi NA, Scheckenbach F, Pflug A, Bülbül A, Catapano AL, Agewall S, Ezhov M, Bots ML, Kiechl S, Orth A, PROG-IMT study group (2017)
    Automatic identification of variables in epidemiological datasets using logic regression
    BMC Med Inform Decis Mak, 17 (1), 40
    DOI 10.1186/s12911-017-0429-1, PubMed 28407816
  339. Fröhlich H, Raman N, Täger T, Schellberg D, Goode KM, Kazmi S, Grundtvig M, Hole T, Cleland JGF, Katus HA, Agewall S, Clark AL, Atar D, Frankenstein L (2017)
    Statins attenuate but do not eliminate the reverse epidemiology of total serum cholesterol in patients with non-ischemic chronic heart failure
    Int J Cardiol, 238, 97-104
    DOI 10.1016/j.ijcard.2017.03.028, PubMed 28342630
  340. Papp J, Zima E, Bover R, Karaliute R, Rossi A, Szymanski C, Troccoli R, Schneider J, Fagerland MW, Camm AJ, Atar D (2017)
    Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry
    Eur Heart J Cardiovasc Pharmacother, 3 (3), 147-150
    DOI 10.1093/ehjcvp/pvx003, PubMed 28329309
  341. Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski JC, Ceconi C, Drexel H, Kjeldsen K, Savarese G, Torp-Pedersen C, Atar D, Lewis BS, Agewall S (2017)
    Gender differences in the effects of cardiovascular drugs
    Eur Heart J Cardiovasc Pharmacother, 3 (3), 163-182
    DOI 10.1093/ehjcvp/pvw042, PubMed 28329228
  342. Kvakkestad KM, Wang Fagerland M, Eritsland J, Halvorsen S (2017)
    Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study
    BMC Cardiovasc Disord, 17 (1), 75
    DOI 10.1186/s12872-017-0508-3, PubMed 28288586
  343. Sanders MF, van Doormaal PJ, Beeftink MMA, Bots ML, Fadl Elmula FEM, Habets J, Hammer F, Hoffmann P, Jacobs L, Mark PB, Persu A, Renkin J, Roditi G, Spiering W, Staessen JA, Taylor AH, Verloop WL, Vink EE, Vonken EJ, Voskuil M, Leiner T, Blankestijn PJ, European Network COordinating research on Renal Denervation (ENCOReD) Consortium (2017)
    Renal artery and parenchymal changes after renal denervation: assessment by magnetic resonance angiography
    Eur Radiol, 27 (9), 3934-3941
    DOI 10.1007/s00330-017-4770-7, PubMed 28271154
  344. Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
    Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
    PLoS One, 12 (3), e0173034
    DOI 10.1371/journal.pone.0173034, PubMed 28253327
  345. Seemann F, Pahlm U, Steding-Ehrenborg K, Ostenfeld E, Erlinge D, Dubois-Rande JL, Jensen SE, Atar D, Arheden H, Carlsson M, Heiberg E (2017)
    Time-resolved tracking of the atrioventricular plane displacement in Cardiovascular Magnetic Resonance (CMR) images
    BMC Med Imaging, 17 (1), 19
    DOI 10.1186/s12880-017-0189-5, PubMed 28241751
  346. Deyab G, Hokstad I, Whist JE, Småstuen MC, Agewall S, Lyberg T, Bottazzi B, Meroni PL, Leone R, Hjeltnes G, Hollan I (2017)
    Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
    PLoS One, 12 (2), e0169830
    DOI 10.1371/journal.pone.0169830, PubMed 28225768
  347. Brolin EB, Agewall S, Cederlund K, Ekenbäck C, Henareh L, Malmqvist K, Rück A, Svensson A, Tornvall P (2017)
    Plasma biomarker levels and non-obstructive coronary artery disease determined by coronary computed tomography angiography
    Clin Physiol Funct Imaging, 38 (2), 246-253
    DOI 10.1111/cpf.12407, PubMed 28168796
  348. Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P, WG on Cardiovascular Pharmacotherapy (2017)
    ESC working group position paper on myocardial infarction with non-obstructive coronary arteries
    Eur Heart J, 38 (3), 143-153
    DOI 10.1093/eurheartj/ehw149, PubMed 28158518
  349. Rubboli A, Agewall S, Huber K, Lip GYH (2017)
    New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose
    Eur J Intern Med, 40, e11-e12
    DOI 10.1016/j.ejim.2017.01.003, PubMed 28087220
  350. Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H (2017)
    Comprehensive efforts to increase adherence to statin therapy
    Eur Heart J, 38 (32), 2473-2479
    DOI 10.1093/eurheartj/ehw628, PubMed 28077470
  351. Atar D (2017)
    European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition
    Eur Heart J Cardiovasc Pharmacother, 3 (1), 3-4
    DOI 10.1093/ehjcvp/pvw024, PubMed 28062654
  352. Agewall S (2017)
    Anticoagulation, atherosclerosis, and heart failure
    Eur Heart J Cardiovasc Pharmacother, 3 (1), 1-2
    DOI 10.1093/ehjcvp/pvw037, PubMed 28062653
  353. Fossum S, Vikanes ÅV, Naess Ø, Vos L, Grotmol T, Halvorsen S (2016)
    Hyperemesis gravidarum and long-term mortality: a population-based cohort study
    BJOG, 124 (7), 1080-1087
    DOI 10.1111/1471-0528.14454, PubMed 27981734
  354. Atar D, Benussi S, Kirchhof P (2016)
    'Ten Commandments' of 2016 ESC Guidelines for the management of atrial fibrillation
    Eur Heart J, 37 (38), 2853
    DOI 10.1093/eurheartj/ehw370, PubMed 27923817
  355. Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
    Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients
    Int J Cardiol, 227, 876-881
    DOI 10.1016/j.ijcard.2016.11.302, PubMed 27915085
  356. Halvorsen S, Storey RF, Rocca B, Sibbing D, Ten Berg J, Grove EL, Weiss TW, Collet JP, Andreotti F, Gulba DC, Lip GYH, Husted S, Vilahur G, Morais J, Verheugt FWA, Lanas A, Al-Shahi Salman R, Steg PG, Huber K, ESC Working Group on Thrombosis (2017)
    Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis
    Eur Heart J, 38 (19), 1455-1462
    DOI 10.1093/eurheartj/ehw454, PubMed 27789570
  357. Agewall S, Lewis BS, Atar D (2016)
    Cardiovascular pharmacotherapy
    Int J Cardiol, 224, 412-415
    DOI 10.1016/j.ijcard.2016.09.065, PubMed 27690338
  358. Halvorsen S, Ghanima W, Fride Tvete I, Hoxmark C, Falck P, Solli O, Jonasson C (2016)
    A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants
    Eur Heart J Cardiovasc Pharmacother, 3 (1), 28-36
    DOI 10.1093/ehjcvp/pvw031, PubMed 27680880
  359. Camm AJ, Accetta G, Ambrosio G, Atar D, Bassand JP, Berge E, Cools F, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Kayani G, Koretsune Y, Mantovani LG, Misselwitz F, Oh S, Turpie AG, Verheugt FW, Kakkar AK, GARFIELD-AF Investigators (2016)
    Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
    Heart, 103 (4), 307-314
    DOI 10.1136/heartjnl-2016-309832, PubMed 27647168
  360. Agewall S (2016)
    The application to MEDLINE from European Heart Journal-Cardiovascular Pharmacotherapy has been accepted!
    Eur Heart J Cardiovasc Pharmacother, 2 (4), 207-8
    DOI 10.1093/ehjcvp/pvw021, PubMed 27600901
  361. Jortveit J, Govatsmark RE, Langørgen J, Hole T, Mannsverk J, Olsen S, Risøe C, Halvorsen S (2016)
    Gender differences in the assessment and treatment of myocardial infarction
    Tidsskr Nor Laegeforen, 136 (14-15), 1215-22
    DOI 10.4045/tidsskr.16.0224, PubMed 27554562
  362. Agewall S (2015)
    Cardiovascular Pharmacotherapy is moving!
    Eur Heart J Cardiovasc Pharmacother, 1 (3), 149
    DOI 10.1093/ehjcvp/pvv025, PubMed 27533986
  363. Ezekowitz JA, Lewis BS, Lopes RD, Wojdyla DM, McMurray JJ, Hanna M, Atar D, Cecilia Bahit M, Keltai M, Lopez-Sendon JL, Pais P, Ruzyllo W, Wallentin L, Granger CB, Alexander JH (2015)
    Clinical outcomes of patients with diabetes and atrial fibrillation treated with apixaban: results from the ARISTOTLE trial
    Eur Heart J Cardiovasc Pharmacother, 1 (2), 86-94
    DOI 10.1093/ehjcvp/pvu024, PubMed 27533976
  364. Agewall S (2015)
    European Heart Journal - CVP: what is next?
    Eur Heart J Cardiovasc Pharmacother, 1 (2), 73
    DOI 10.1093/ehjcvp/pvv009, PubMed 27533970
  365. Atar D, Agewall S (2015)
    End of story? Studies on prevention of reperfusion injury encounter perpetual defeats
    Eur Heart J Cardiovasc Pharmacother, 1 (1), 46-7
    DOI 10.1093/ehjcvp/pvu018, PubMed 27533965
  366. De Blois J, Fagerland MW, Grundtvig M, Semb AG, Gullestad L, Westheim A, Hole T, Atar D, Agewall S (2015)
    ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry
    Eur Heart J Cardiovasc Pharmacother, 1 (1), 31-6
    DOI 10.1093/ehjcvp/pvu010, PubMed 27533962
  367. Agewall S (2015)
    European Heart Journal - Cardiovascular Pharmacotherapy: a new journal within the European Heart Journal family
    Eur Heart J Cardiovasc Pharmacother, 1 (1), 1
    DOI 10.1093/ehjcvp/pvu022, PubMed 27533955
  368. Agewall S (2016)
    News from EHJCVP
    Eur Heart J Cardiovasc Pharmacother, 2 (3), 141
    DOI 10.1093/ehjcvp/pvw010, PubMed 27533754
  369. Schmidt M, Lamberts M, Olsen AM, Fosbøll EL, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C (2016)
    Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
    Eur Heart J Cardiovasc Pharmacother, 2 (2), 108-18
    DOI 10.1093/ehjcvp/pvv054, PubMed 27533522
  370. Agewall S (2016)
    Update from EHJ CVP
    Eur Heart J Cardiovasc Pharmacother, 2 (2), 77-8
    DOI 10.1093/ehjcvp/pvw004, PubMed 27533516
  371. Agewall S (2016)
    Second year of a journal
    Eur Heart J Cardiovasc Pharmacother, 2 (1), 1-2
    DOI 10.1093/ehjcvp/pvv049, PubMed 27533054
  372. Agewall S (2015)
    Starting up a new Journal within the European Heart Journal Family
    Eur Heart J Cardiovasc Pharmacother, 1 (4), 213
    DOI 10.1093/ehjcvp/pvv033, PubMed 27532442
  373. Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L, Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) Investigators (2016)
    Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial
    JAMA Cardiol, 1 (6), 673-81
    DOI 10.1001/jamacardio.2016.1829, PubMed 27463942
  374. McGuire DK, Van de Werf F, Armstrong PW, Standl E, Koglin J, Green JB, Bethel MA, Cornel JH, Lopes RD, Halvorsen S, Ambrosio G, Buse JB, Josse RG, Lachin JM, Pencina MJ, Garg J, Lokhnygina Y, Holman RR, Peterson ED, Trial Evaluating Cardiovascular Outcomes With Sitagliptin (TECOS) Study Group (2016)
    Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial
    JAMA Cardiol, 1 (2), 126-35
    DOI 10.1001/jamacardio.2016.0103, PubMed 27437883
  375. Gresslien T, Agewall S (2016)
    Troponin and exercise
    Int J Cardiol, 221, 609-21
    DOI 10.1016/j.ijcard.2016.06.243, PubMed 27420587
  376. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
    Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
    J Am Heart Assoc, 5 (6)
    DOI 10.1161/JAHA.115.003014, PubMed 27412895
  377. Nordlund D, Heiberg E, Carlsson M, Fründ ET, Hoffmann P, Koul S, Atar D, Aletras AH, Erlinge D, Engblom H, Arheden H (2016)
    Extent of Myocardium at Risk for Left Anterior Descending Artery, Right Coronary Artery, and Left Circumflex Artery Occlusion Depicted by Contrast-Enhanced Steady State Free Precession and T2-Weighted Short Tau Inversion Recovery Magnetic Resonance Imaging
    Circ Cardiovasc Imaging, 9 (7)
    DOI 10.1161/CIRCIMAGING.115.004376, PubMed 27412659
  378. Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Floch CL, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M et al. (2016)
    Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]
    Eur J Heart Fail, 18 (6), 727
    DOI 10.1002/ejhf.591, PubMed 27324688
  379. Halvorsen S, Jortveit J, Hasvold P, Thuresson M, Øie E (2016)
    Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
    BMC Cardiovasc Disord, 16, 115
    DOI 10.1186/s12872-016-0283-6, PubMed 27246583
  380. Engblom H, Tufvesson J, Jablonowski R, Carlsson M, Aletras AH, Hoffmann P, Jacquier A, Kober F, Metzler B, Erlinge D, Atar D, Arheden H, Heiberg E (2016)
    A new automatic algorithm for quantification of myocardial infarction imaged by late gadolinium enhancement cardiovascular magnetic resonance: experimental validation and comparison to expert delineations in multi-center, multi-vendor patient data
    J Cardiovasc Magn Reson, 18 (1), 27
    DOI 10.1186/s12968-016-0242-5, PubMed 27145749
  381. Graham JJ, Yan AT, Tan MK, Cantor WJ, DiMario C, Jolly SS, Halvorsen S, Fernandez-Aviles F, Le May MR, Scheller B, Borgia F, Piscione F, Madan M, Goodman SG (2016)
    Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials
    Cardiovasc Revasc Med, 17 (5), 295-301
    DOI 10.1016/j.carrev.2016.03.008, PubMed 27116940
  382. Anker SD, Schroeder S, Atar D, Bax JJ, Ceconi C, Cowie MR, Crisp A, Dominjon F, Ford I, Ghofrani HA, Gropper S, Hindricks G, Hlatky MA, Holcomb R, Honarpour N, Jukema JW, Kim AM, Kunz M, Lefkowitz M, Le Floch C, Landmesser U, McDonagh TA, McMurray JJ, Merkely B, Packer M et al. (2016)
    Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency
    Eur J Heart Fail, 18 (5), 482-9
    DOI 10.1002/ejhf.516, PubMed 27071916
  383. Sandhu RK, Ezekowitz J, Andersson U, Alexander JH, Granger CB, Halvorsen S, Hanna M, Hijazi Z, Jansky P, Lopes RD, Wallentin L (2016)
    The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial
    Eur Heart J, 37 (38), 2869-2878
    DOI 10.1093/eurheartj/ehw124, PubMed 27071819
  384. Nordlund D, Klug G, Heiberg E, Koul S, Larsen TH, Hoffmann P, Metzler B, Erlinge D, Atar D, Aletras AH, Carlsson M, Engblom H, Arheden H (2016)
    Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction
    Eur Heart J Cardiovasc Imaging, 17 (7), 744-53
    DOI 10.1093/ehjci/jew027, PubMed 27002140
  385. Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C (2016)
    Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology
    Eur Heart J, 37 (13), 1015-23
    DOI 10.1093/eurheartj/ehv505, PubMed 26984863
  386. Engblom H, Heiberg E, Erlinge D, Jensen SE, Nordrehaug JE, Dubois-Randé JL, Halvorsen S, Hoffmann P, Koul S, Carlsson M, Atar D, Arheden H (2016)
    Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint
    J Am Heart Assoc, 5 (3), e002708
    DOI 10.1161/JAHA.115.002708, PubMed 26961520
  387. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Collet JP, Halvorsen S, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Ricci F, Sibbing D, Siegbahn A, Storey RF, Ten Berg J, Verheugt FW, Weitz JI (2016)
    Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
    Thromb Haemost, 115 (4), 685-711
    DOI 10.1160/TH15-09-0703, PubMed 26952877
  388. von Lueder TG, Hopper I, Kotecha D, Atar D (2016)
    In memoriam Henry Krum, 1958-2015
    Cardiology, 134 (2), 107-8
    DOI 10.1159/000444294, PubMed 26950607
  389. Tufvesson J, Carlsson M, Aletras AH, Engblom H, Deux JF, Koul S, Sörensson P, Pernow J, Atar D, Erlinge D, Arheden H, Heiberg E (2016)
    Automatic segmentation of myocardium at risk from contrast enhanced SSFP CMR: validation against expert readers and SPECT
    BMC Med Imaging, 16, 19
    DOI 10.1186/s12880-016-0124-1, PubMed 26946139
  390. Hilde JM, Skjørten I, Hansteen V, Melsom MN, Atar D, Hisdal J, Humerfelt S, Steine K (2016)
    Assessment of Right Ventricular Afterload in COPD
    COPD, 13 (2), 176-85
    DOI 10.3109/15412555.2015.1057275, PubMed 26914261
  391. Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T (2016)
    Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
    Eur Heart J, 37 (21), 1671-80
    DOI 10.1093/eurheartj/ehw022, PubMed 26903532
  392. Bainey KR, Fresco C, Zheng Y, Halvorsen S, Carvalho A, Ostojic M, Goldstein P, Gershlick AH, Westerhout CM, Van de Werf F, Armstrong PW, STREAM Investigators (2016)
    Implications of ischaemic area at risk and mode of reperfusion in ST-elevation myocardial infarction
    Heart, 102 (7), 527-33
    DOI 10.1136/heartjnl-2015-308075, PubMed 26783237
  393. Rao MP, Halvorsen S, Wojdyla D, Thomas L, Alexander JH, Hylek EM, Hanna M, Bahit MC, Lopes RD, De Caterina R, Erol C, Goto S, Lanas F, Lewis BS, Husted S, Gersh BJ, Wallentin L, Granger CB, Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Steering Committee and Investigators (2015)
    Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    J Am Heart Assoc, 4 (12)
    DOI 10.1161/JAHA.115.002015, PubMed 26627878
  394. Bang CN, Greve AM, La Cour M, Boman K, Gohlke-Bärwolf C, Ray S, Pedersen T, Rossebø A, Okin PM, Devereux RB, Wachtell K (2015)
    Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
    Am J Cardiol, 116 (12), 1840-4
    DOI 10.1016/j.amjcard.2015.09.026, PubMed 26602073
  395. Atar D, Agewall S (2015)
    Morphine in myocardial infarction: balancing on the tight rope
    Eur Heart J, 37 (3), 253-5
    DOI 10.1093/eurheartj/ehv546, PubMed 26491111
  396. Gerdts E, Rossebø AB, Pedersen TR, Cioffi G, Lønnebakken MT, Cramariuc D, Rogge BP, Devereux RB (2015)
    Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis
    Circ Cardiovasc Imaging, 8 (11), e003644; discussion e003644
    DOI 10.1161/CIRCIMAGING.115.003644, PubMed 26489804
  397. Ellingsrud C, Agewall S (2015)
    Morphine in the treatment of acute pulmonary oedema--Why?
    Int J Cardiol, 202, 870-3
    DOI 10.1016/j.ijcard.2015.10.014, PubMed 26476045
  398. Steffel J, Atar D (2015)
    Non-vitamin K oral anticoagulants in 'valvular' atrial fibrillation: a call for action
    Europace, 18 (1), 1-3
    DOI 10.1093/europace/euv318, PubMed 26462701
  399. von Lueder TG, Girerd N, Atar D, Agewall S, Lamiral Z, Kanbay M, Pitt B, Dickstein K, Zannad F, Rossignol P, High-Risk Myocardial Infarction Database Initiative Investigators (2015)
    Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative
    Eur J Heart Fail, 17 (11), 1144-51
    DOI 10.1002/ejhf.419, PubMed 26424212
  400. Hansen CH, Ritschel V, Halvorsen S, Andersen GØ, Bjørnerheim R, Eritsland J, Arnesen H, Seljeflot I (2015)
    Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
    Thromb J, 13, 31
    DOI 10.1186/s12959-015-0061-1, PubMed 26396552
  401. Lindholm D, Storey RF, Christersson C, Halvorsen S, Grove EL, Braun OÖ, Varenhorst C, James SK (2015)
    Design and rationale of TROCADERO: A TRial Of Caffeine to Alleviate DyspnEa Related to ticagrelOr
    Am Heart J, 170 (3), 465-70
    DOI 10.1016/j.ahj.2015.06.014, PubMed 26385029
  402. Vinereanu D, Stevens SR, Alexander JH, Al-Khatib SM, Avezum A, Bahit MC, Granger CB, Lopes RD, Halvorsen S, Hanna M, Husted S, Hylek EM, Mărgulescu AD, Wallentin L, Atar D (2015)
    Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial
    Eur Heart J, 36 (46), 3268-75
    DOI 10.1093/eurheartj/ehv447, PubMed 26371113
  403. Shavadia J, Zheng Y, Dianati Maleki N, Huber K, Halvorsen S, Goldstein P, Gershlick AH, Wilcox R, Van de Werf F, Armstrong PW (2015)
    Infarct Size, Shock, and Heart Failure: Does Reperfusion Strategy Matter in Early Presenting Patients With ST-Segment Elevation Myocardial Infarction?
    J Am Heart Assoc, 4 (8), e002049
    DOI 10.1161/JAHA.115.002049, PubMed 26304934
  404. Fröhlich H, Zhao J, Täger T, Cebola R, Schellberg D, Katus HA, Grundtvig M, Hole T, Atar D, Agewall S, Frankenstein L (2015)
    Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study
    Circ Heart Fail, 8 (5), 887-96
    DOI 10.1161/CIRCHEARTFAILURE.114.001701, PubMed 26175538
  405. Abdel-Qadir H, Yan AT, Tan M, Borgia F, Piscione F, Di Mario C, Halvorsen S, Cantor WJ, Westerhout CM, Scheller B, Le May MR, Fernandez-Aviles F, Sánchez PL, Lee DS, Goodman SG (2015)
    Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysis
    Heart, 101 (19), 1554-61
    DOI 10.1136/heartjnl-2015-307815, PubMed 26175478
  406. Andreotti F, Rocca B, Husted S, Ajjan RA, ten Berg J, Cattaneo M, Collet JP, De Caterina R, Fox KA, Halvorsen S, Huber K, Hylek EM, Lip GY, Montalescot G, Morais J, Patrono C, Verheugt FW, Wallentin L, Weiss TW, Storey RF, ESC Thrombosis Working Group (2015)
    Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
    Eur Heart J, 36 (46), 3238-49
    DOI 10.1093/eurheartj/ehv304, PubMed 26163482
  407. Brolin EB, Agewall S, Brismar TB, Caidahl K, Tornvall P, Cederlund K (2015)
    Neither endothelial function nor carotid artery intima-media thickness predicts coronary computed tomography angiography plaque burden in clinically healthy subjects: a cross-sectional study
    BMC Cardiovasc Disord, 15, 63
    DOI 10.1186/s12872-015-0061-x, PubMed 26148508
  408. Hollan I, Dessein PH, Ronda N, Wasko MC, Svenungsson E, Agewall S, Cohen-Tervaert JW, Maki-Petaja K, Grundtvig M, Karpouzas GA, Meroni PL (2015)
    Prevention of cardiovascular disease in rheumatoid arthritis
    Autoimmun Rev, 14 (10), 952-69
    DOI 10.1016/j.autrev.2015.06.004, PubMed 26117596
  409. Khan R, Lopes RD, Neely ML, Stevens SR, Harrington RA, Diaz R, Cools F, Jansky P, Montalescot G, Atar D, Lopez-Sendon J, Flather M, Liaw D, Wallentin L, Alexander JH, Goodman SG, Apixaban for Prevention of Acute Ischemic Safety Events (APPRAISE)-2 Steering Committee and Investigators (2015)
    Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome
    Heart, 101 (18), 1475-84
    DOI 10.1136/heartjnl-2014-307346, PubMed 26109589
  410. Sticherling C, Marin F, Birnie D, Boriani G, Calkins H, Dan GA, Gulizia M, Halvorsen S, Hindricks G, Kuck KH, Moya A, Potpara T, Roldan V, Tilz R, Lip GY (2015)
    Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)
    Europace, 17 (8), 1197-214
    DOI 10.1093/europace/euv190, PubMed 26105732
  411. Rubboli A, Agewall S, Huber K, Lip GY (2015)
    New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint
    Int J Cardiol, 196, 133-8
    DOI 10.1016/j.ijcard.2015.06.006, PubMed 26093527
  412. Jackson N, Atar D, Borentain M, Breithardt G, van Eickels M, Endres M, Fraass U, Friede T, Hannachi H, Janmohamed S, Kreuzer J, Landray M, Lautsch D, Le Floch C, Mol P, Naci H, Samani NJ, Svensson A, Thorstensen C, Tijssen J, Vandzhura V, Zalewski A, Kirchhof P (2015)
    Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
    Eur Heart J, 37 (9), 747-54
    DOI 10.1093/eurheartj/ehv213, PubMed 26077039
  413. Atar D (2015)
    The National Cardiac Societies of the European Society of Cardiology
    Eur Heart J, 36 (21), 1278
    DOI 10.1093/eurheartj/ehv091, PubMed 26034059
  414. Ladeiras-Lopes R, Agewall S, Tawakol A, Staels B, Stein E, Mentz RJ, Leite-Moreira A, Zannad F, Koenig W (2015)
    Atherosclerosis: Recent trials, new targets and future directions
    Int J Cardiol, 192, 72-81
    DOI 10.1016/j.ijcard.2015.05.013, PubMed 26002254
  415. De Blois J, Kjellstrom T, Agewall S, Ezekowitz JA, Armstrong PW, Atar D (2015)
    The Effects of Climate Change on Cardiac Health
    Cardiology, 131 (4), 209-17
    DOI 10.1159/000398787, PubMed 25997478
  416. Steffel J, Giugliano RP, Braunwald E, Murphy SA, Atar D, Heidbuchel H, Camm AJ, Antman EM, Ruff CT (2015)
    Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial
    Eur Heart J, 36 (33), 2239-45
    DOI 10.1093/eurheartj/ehv201, PubMed 25971288
  417. Tornvall P, Gerbaud E, Behaghel A, Chopard R, Collste O, Laraudogoitia E, Leurent G, Meneveau N, Montaudon M, Perez-David E, Sörensson P, Agewall S (2015)
    Myocarditis or "true" infarction by cardiac magnetic resonance in patients with a clinical diagnosis of myocardial infarction without obstructive coronary disease: A meta-analysis of individual patient data
    Atherosclerosis, 241 (1), 87-91
    DOI 10.1016/j.atherosclerosis.2015.04.816, PubMed 25967935
  418. Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, Drexel H, Patak A, Torp-Pedersen C, Kjeldsen KP, Tamargo J (2015)
    Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC
    Eur Heart J, 36 (40), 2677-80
    DOI 10.1093/eurheartj/ehv161, PubMed 25948737
  419. Navarese EP, Kolodziejczak M, Schulze V, Gurbel PA, Tantry U, Lin Y, Brockmeyer M, Kandzari DE, Kubica JM, D'Agostino RB, Kubica J, Volpe M, Agewall S, Kereiakes DJ, Kelm M (2015)
    Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis
    Ann Intern Med, 163 (1), 40-51
    DOI 10.7326/M14-2957, PubMed 25915661
  420. Agewall S (2015)
    How to save six million people per year
    Atherosclerosis, 240 (2), 387-8
    DOI 10.1016/j.atherosclerosis.2015.04.006, PubMed 25881201
  421. Bethke A, Halvorsen S, Bøhmer E, Abdelnoor M, Arnesen H, Hoffmann P (2015)
    Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty)
    EuroIntervention, 11 (5), 518-24
    DOI 10.4244/EIJY15M04_02, PubMed 25868877
  422. Wang BH, von Lueder TG, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H (2015)
    Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis
    Int J Cardiol, 186, 104-5
    DOI 10.1016/j.ijcard.2015.03.116, PubMed 25828104
  423. Hodt A, Hisdal J, Stugaard M, Stranden E, Atar D, Steine K (2015)
    Increased LV apical untwist during preload reduction in healthy humans: an echocardiographic speckle tracking study during lower body negative pressure
    Physiol Rep, 3 (3)
    DOI 10.14814/phy2.12330, PubMed 25802362
  424. Kvakkestad KM, Abdelnoor M, Claussen PA, Eritsland J, Fossum E, Halvorsen S (2015)
    Long-term survival in octogenarians and older patients with ST-elevation myocardial infarction in the era of primary angioplasty: A prospective cohort study
    Eur Heart J Acute Cardiovasc Care, 5 (3), 243-52
    DOI 10.1177/2048872615574706, PubMed 25753053
  425. Gershlick AH, Westerhout CM, Armstrong PW, Huber K, Halvorsen S, Steg PG, Ostojic M, Goldstein P, Carvalho AC, Van de Werf F, Wilcox RG (2015)
    Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged
    Heart, 101 (9), 692-8
    DOI 10.1136/heartjnl-2014-306686, PubMed 25691510
  426. Blyme A, Asferg C, Nielsen OW, Sehestedt T, Kesäniemi YA, Gohlke-Bärwolf C, Boman K, Willenheimer R, Ray S, Nienaber CA, Rossebø A, Wachtell K, Olsen MH (2015)
    High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy
    Open Heart, 2 (1), e000152
    DOI 10.1136/openhrt-2014-000152, PubMed 25685360
  427. Mueller C, Auer J, Halvorsen S (2015)
    Cardiac troponin elevations in acute non-coronary disease: Helpful or not?
    Eur Heart J Acute Cardiovasc Care, 4 (5), 429-30
    DOI 10.1177/2048872615573921, PubMed 25678669
  428. Hall TS, Hallén J, Krucoff MW, Roe MT, Brennan DM, Agewall S, Atar D, Lincoff AM (2014)
    Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
    Am Heart J, 169 (2), 257-265.e1
    DOI 10.1016/j.ahj.2014.10.015, PubMed 25641535
  429. Madan M, Halvorsen S, Di Mario C, Tan M, Westerhout CM, Cantor WJ, Le May MR, Borgia F, Piscione F, Scheller B, Armstrong PW, Fernandez-Aviles F, Sanchez PL, Graham JJ, Yan AT, Goodman SG (2014)
    Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: a patient-level analysis of the randomized early routine invasive clinical trials
    JACC Cardiovasc Interv, 8 (1 Pt B), 166-174
    DOI 10.1016/j.jcin.2014.09.005, PubMed 25616922
  430. Claussen PA, Abdelnoor M, Kvakkestad KM, Eritsland J, Halvorsen S (2014)
    Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
    Vasc Health Risk Manag, 10, 683-9
    DOI 10.2147/VHRM.S72764, PubMed 25525366
  431. Ellingsrud C, Agewall S (2014)
    [Morphine in the treatment of acute pulmonary oedema]
    Tidsskr Nor Laegeforen, 134 (23-24), 2272-5
    DOI 10.4045/tidsskr.14.0359, PubMed 25492336
  432. Das D, Bakal JA, Westerhout CM, Hernandez AF, O'Connor CM, Atar D, McMurray JJ, Armstrong PW, Ezekowitz JA (2014)
    The association between meteorological events and acute heart failure: new insights from ASCEND-HF
    Int J Cardiol, 177 (3), 819-24
    DOI 10.1016/j.ijcard.2014.11.066, PubMed 25465826
  433. Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR, Kjeldsen K, Jankowska EA, Atar D, Butler J, Fiuzat M, Zannad F, Pitt B, O'Connor CM (2014)
    Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction
    J Am Coll Cardiol, 64 (21), 2281-93
    DOI 10.1016/j.jacc.2014.08.036, PubMed 25456761
  434. Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L (2014)
    Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy
    Clin Chem, 61 (2), 368-78
    DOI 10.1373/clinchem.2014.226936, PubMed 25451868
  435. Bagai A, Tan M, Di Mario C, Halvorsen S, Cantor WJ, Le May MR, Fernandez-Aviles F, Scheller B, Armstrong PW, Borgia F, Piscione F, Sánchez PL, Westerhout CM, Goodman SG, Yan AT (2014)
    Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials
    Am Heart J, 168 (5), 757-65
    DOI 10.1016/j.ahj.2014.07.027, PubMed 25440805
  436. Greve AM, Bang CN, Berg RM, Egstrup K, Rossebø AB, Boman K, Nienaber CA, Ray S, Gohlke-Baerwolf C, Nielsen OW, Okin PM, Devereux RB, Køber L, Wachtell K (2014)
    Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study
    Int J Cardiol, 180, 122-8
    DOI 10.1016/j.ijcard.2014.11.181, PubMed 25438232
  437. Willeit P, Thompson SG, Agewall S, Bergström G, Bickel H, Catapano AL, Chien KL, de Groot E, Empana JP, Etgen T, Franco OH, Iglseder B, Johnsen SH, Kavousi M, Lind L, Liu J, Mathiesen EB, Norata GD, Olsen MH, Papagianni A, Poppert H, Price JF, Sacco RL, Yanez DN, Zhao D et al. (2014)
    Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration
    Eur J Prev Cardiol, 23 (2), 194-205
    DOI 10.1177/2047487314560664, PubMed 25416041
  438. von Lueder TG, Wang BH, Kompa AR, Huang L, Webb R, Jordaan P, Atar D, Krum H (2014)
    Angiotensin receptor neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy
    Circ Heart Fail, 8 (1), 71-8
    DOI 10.1161/CIRCHEARTFAILURE.114.001785, PubMed 25362207
  439. Jortveit J, Govatsmark RE, Digre TA, Risøe C, Hole T, Mannsverk J, Slørdahl SA, Halvorsen S (2014)
    Myocardial infarction in Norway in 2013
    Tidsskr Nor Laegeforen, 134 (19), 1841-6
    DOI 10.4045/tidsskr.14.0804, PubMed 25314984
  440. Jander N, Hochholzer W, Kaufmann BA, Bahlmann E, Gerdts E, Boman K, Chambers JB, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Wachtell K, Gohlke-Bärwolf C, Neumann FJ, Minners J (2014)
    Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF
    Heart, 100 (24), 1946-53
    DOI 10.1136/heartjnl-2014-305763, PubMed 25217488
  441. van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E, Lee D, Bodi V, Klug G, Metzler B, Delewi R, Bernhardt P, Rottbauer W, Boersma E, Zijlstra F, van Geuns RJ (2014)
    Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients
    JACC Cardiovasc Imaging, 7 (9), 930-9
    DOI 10.1016/j.jcmg.2014.05.010, PubMed 25212799
  442. Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Flem Jacobsen A, Granan LP, Halvorsen S, Guyatt G, Vandvik PO (2014)
    Applying new strategies for the national adaptation, updating, and dissemination of trustworthy guidelines: results from the Norwegian adaptation of the Antithrombotic Therapy and the Prevention of Thrombosis, 9th Ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
    Chest, 146 (3), 735-761
    DOI 10.1378/chest.13-2993, PubMed 25180724
  443. Kristiansen A, Brandt L, Agoritsas T, Akl EA, Berge E, Bondi J, Dahm AE, Granan LP, Halvorsen S, Holme PA, Flem Jacobsen A, Jacobsen EM, Neumann I, Sandset PM, Sætre T, Tveit A, Vartdal T, Guyatt G, Vandvik PO (2014)
    Adaptation of trustworthy guidelines developed using the GRADE methodology: a novel five-step process
    Chest, 146 (3), 727-734
    DOI 10.1378/chest.13-2828, PubMed 25180723
  444. Atar D, Arheden H, Berdeaux A, Bonnet JL, Carlsson M, Clemmensen P, Cuvier V, Danchin N, Dubois-Randé JL, Engblom H, Erlinge D, Firat H, Halvorsen S, Hansen HS, Hauke W, Heiberg E, Koul S, Larsen AI, Le Corvoisier P, Nordrehaug JE, Paganelli F, Pruss RM, Rousseau H, Schaller S, Sonou G et al. (2014)
    Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results
    Eur Heart J, 36 (2), 112-9
    DOI 10.1093/eurheartj/ehu331, PubMed 25179768
  445. Sinnaeve PR, Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Lambert Y, Danays T, Soulat L, Halvorsen S, Ortiz FR, Vandenberghe K, Regelin A, Bluhmki E, Bogaerts K, Van de Werf F, STREAM investigators (2014)
    ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up
    Circulation, 130 (14), 1139-45
    DOI 10.1161/CIRCULATIONAHA.114.009570, PubMed 25161043
  446. Lip GY, Windecker S, Huber K, Kirchhof P, Marin F, Ten Berg JM, Haeusler KG, Boriani G, Capodanno D, Gilard M, Zeymer U, Lane D, Document Reviewers, Storey RF, Bueno H, Collet JP, Fauchier L, Halvorsen S, Lettino M, Morais J, Mueller C, Potpara TS, Rasmussen LH, Rubboli A, Tamargo J et al. (2014)
    Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)
    Eur Heart J, 35 (45), 3155-79
    DOI 10.1093/eurheartj/ehu298, PubMed 25154388
  447. Omland T, Røsjø H, Giannitsis E, Agewall S (2014)
    Troponins in heart failure
    Clin Chim Acta, 443, 78-84
    DOI 10.1016/j.cca.2014.08.016, PubMed 25151947
  448. Lip GY, Laroche C, Boriani G, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Maggioni AP, Tavazzi L (2014)
    Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
    Europace, 17 (2), 194-206
    DOI 10.1093/europace/euu201, PubMed 25149078
  449. Kjeldsen SE, Sørensen H, Fadl Elmula FE, Brekke M, Gjønnæss E, Hjørnholm U, Kjære VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
    [Re: Renal sympathetic denervation in treatment-resistant hypertension]
    Tidsskr Nor Laegeforen, 134 (15), 1449-50
    DOI 10.4045/tidsskr.14.0931, PubMed 25138398
  450. Greve AM, Dalsgaard M, Bang CN, Egstrup K, Rossebø AB, Boman K, Cramariuc D, Nienaber CA, Ray S, Gohlke-Baerwolf C, Okin PM, Devereux RB, Køber L, Wachtell K (2014)
    Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
    Am J Cardiol, 114 (5), 751-6
    DOI 10.1016/j.amjcard.2014.06.006, PubMed 25048345
  451. Halvorsen S, Andreotti F, ten Berg JM, Cattaneo M, Coccheri S, Marchioli R, Morais J, Verheugt FW, De Caterina R (2014)
    Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis
    J Am Coll Cardiol, 64 (3), 319-27
    DOI 10.1016/j.jacc.2014.03.049, PubMed 25034070
  452. Bang CN, Greve AM, Køber L, Rossebø AB, Ray S, Boman K, Nienaber CA, Devereux RB, Wachtell K (2014)
    Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis
    Int J Cardiol, 175 (3), 492-8
    DOI 10.1016/j.ijcard.2014.06.013, PubMed 25012498
  453. Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
    Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
    Cytokine, 69 (1), 131-5
    DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044
  454. Anker SD, Agewall S, Borggrefe M, Calvert M, Jaime Caro J, Cowie MR, Ford I, Paty JA, Riley JP, Swedberg K, Tavazzi L, Wiklund I, Kirchhof P (2014)
    The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
    Eur Heart J, 35 (30), 2001-9
    DOI 10.1093/eurheartj/ehu205, PubMed 24904027
  455. Greve AM, Dalsgaard M, Bang CN, Egstrup K, Ray S, Boman K, Rossebø AB, Gohlke-Baerwolf C, Devereux RB, Køber L, Wachtell K (2014)
    Stroke in patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
    Stroke, 45 (7), 1939-46
    DOI 10.1161/STROKEAHA.114.005296, PubMed 24903982
  456. Hall TS, Herrscher TE, Jarolim P, Fagerland MW, Jensen T, Agewall S, Atar D, Hallén J (2014)
    Myeloid-related protein-8/14 and C-reactive protein in individuals evaluated for obstructive sleep apnea
    Sleep Med, 15 (7), 762-8
    DOI 10.1016/j.sleep.2014.03.008, PubMed 24841106
  457. von Lueder TG, Atar D, Krum H (2014)
    Current role of neprilysin inhibitors in hypertension and heart failure
    Pharmacol Ther, 144 (1), 41-9
    DOI 10.1016/j.pharmthera.2014.05.002, PubMed 24836726
  458. Bøhmer E, Kristiansen IS, Arnesen H, Halvorsen S (2014)
    Health-related quality of life after myocardial infarction, does choice of method make a difference?
    Scand Cardiovasc J, 48 (4), 216-22
    DOI 10.3109/14017431.2014.923581, PubMed 24828790
  459. Lincoff AM, Roe M, Aylward P, Galla J, Rynkiewicz A, Guetta V, Zelizko M, Kleiman N, White H, McErlean E, Erlinge D, Laine M, Dos Santos Ferreira JM, Goodman S, Mehta S, Atar D, Suryapranata H, Jensen SE, Forster T, Fernandez-Ortiz A, Schoors D, Radke P, Belli G, Brennan D, Bell G et al. (2014)
    Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial
    Eur Heart J, 35 (37), 2516-23
    DOI 10.1093/eurheartj/ehu177, PubMed 24796339
  460. Limalanathan S, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P, Eritsland J (2014)
    Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
    J Am Heart Assoc, 3 (2), e000679
    DOI 10.1161/JAHA.113.000679, PubMed 24760962
  461. Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
    The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
    Mediators Inflamm, 2014, 608414
    DOI 10.1155/2014/608414, PubMed 24737925
  462. Agewall S (2014)
    [Final reply: follow the Danish example]
    Lakartidningen, 111 (9-10), 405
    PubMed 24707558
  463. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ (2013)
    IL-6 signalling in patients with acute ST-elevation myocardial infarction
    Results Immunol, 4, 8-13
    DOI 10.1016/j.rinim.2013.11.002, PubMed 24707455
  464. von Lueder TG, Atar D (2014)
    Comorbidities and polypharmacy
    Heart Fail Clin, 10 (2), 367-72
    DOI 10.1016/j.hfc.2013.12.001, PubMed 24656112
  465. Radke PW, Halvorsen S, Jukema JW, Kolh P, Annemans L, Postma MJ, Ardissino D, Kristensen SD, Bassand JP, Collet JP, Morais J, Tuñón J, Halcox J (2014)
    Networks for improving care in patients with acute coronary syndrome: A framework
    Acute Card Care, 16 (2), 41-8
    DOI 10.3109/17482941.2014.881502, PubMed 24654609
  466. Agewall S (2014)
    [Why all these guidelines?]
    Lakartidningen, 111 (5), 129
    PubMed 24624760
  467. Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A (2014)
    Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension
    Hypertension, 63 (5), 991-9
    DOI 10.1161/HYPERTENSIONAHA.114.03246, PubMed 24591332
  468. Halvorsen S, Atar D, Yang H, De Caterina R, Erol C, Garcia D, Granger CB, Hanna M, Held C, Husted S, Hylek EM, Jansky P, Lopes RD, Ruzyllo W, Thomas L, Wallentin L (2014)
    Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
    Eur Heart J, 35 (28), 1864-72
    DOI 10.1093/eurheartj/ehu046, PubMed 24561548
  469. Atar D, Bode C, Stuerzenbecher A, Verheugt FW (2014)
    Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade
    Fundam Clin Pharmacol, 28 (4), 353-63
    DOI 10.1111/fcp.12063, PubMed 24494730
  470. Johnson J, Manouras A, Bergholm F, Brodin LÅ, Agewall S, Henareh L (2013)
    The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease
    Clin Physiol Funct Imaging, 34 (5), 389-96
    DOI 10.1111/cpf.12110, PubMed 24438358
  471. Sørensen H, Fadl Elmula FE, Kjeldsen SE, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Fossum E, Os I, Stenehjem A, Høieggen A, Hoffmann P (2014)
    [Renal sympathetic denervation in treatment-resistant hypertension]
    Tidsskr Nor Laegeforen, 134 (1), 32-6
    DOI 10.4045/tidsskr.13.0276, PubMed 24429753
  472. Agewall S, Giannitsis E (2014)
    "Troponin elevation in coronary ischemia and necrosis"
    Curr Atheroscler Rep, 16 (3), 396
    DOI 10.1007/s11883-013-0396-7, PubMed 24425063
  473. Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP (2013)
    A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
    Europace, 16 (3), 308-19
    DOI 10.1093/europace/eut373, PubMed 24351881
  474. Crisby M, Henareh L, Agewall S (2013)
    Relationship between oxidized LDL, IgM, and IgG autoantibodies to ox-LDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction
    Angiology, 65 (10), 932-6
    DOI 10.1177/0003319713512720, PubMed 24288363
  475. Jogestrand T, Agewall S, Gustafsson T, Henareh L (2013)
    Conventional treatment after myocardial infarction in routine clinical practice results in regression of left common carotid intima-media thickness
    Clin Physiol Funct Imaging, 34 (4), 322-6
    DOI 10.1111/cpf.12101, PubMed 24237780
  476. Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, Gersh BJ, Mohan P, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L, ARISTOTLE Investigators (2013)
    High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
    Circulation, 129 (6), 625-34
    DOI 10.1161/CIRCULATIONAHA.113.006286, PubMed 24226808
  477. Catalano M, Poredos P, Brodmann M, Wautrecht JC, Carpentier P, Roztocil K, Nikol S, Diamantopoulos E, Pecsvarady Z, Carlizza A, Sieron A, Stanek A, Olinic D, Stvrtinova V, Kozak M, Agewall S, Gallino A, Jaeger KA, Fitzgerald P, Colgan MP (2013)
    Requirements for angiology/vascular medicine
    Int Angiol, 32 (6), 608-12
    PubMed 24212296
  478. Alexander JH, Lopes RD, Thomas L, Alings M, Atar D, Aylward P, Goto S, Hanna M, Huber K, Husted S, Lewis BS, McMurray JJ, Pais P, Pouleur H, Steg PG, Verheugt FW, Wojdyla DM, Granger CB, Wallentin L (2013)
    Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
    Eur Heart J, 35 (4), 224-32
    DOI 10.1093/eurheartj/eht445, PubMed 24144788
  479. Halvorsen S, Huber K (2013)
    Fibrinolytic treatment of ST-elevation myocardial infarction. Update 2014
    Hamostaseologie, 34 (1), 47-53
    DOI 10.5482/HAMO-13-07-0040, PubMed 24085113
  480. Ghanima W, Atar D, Sandset PM (2013)
    New oral anticoagulants--a review
    Tidsskr Nor Laegeforen, 133 (18), 1940-5
    DOI 10.4045/tidsskr.12.1111, PubMed 24084970
  481. Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Granger CB, ARISTOTLE Investigators (2013)
    High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin
    J Am Coll Cardiol, 63 (1), 52-61
    DOI 10.1016/j.jacc.2013.07.093, PubMed 24055845
  482. Hall TS, Herrscher T, Jarolim P, Fagerland MW, Jensen T, Hallén J, Agewall S, Atar D (2013)
    Obstructive sleep apnea: no independent association to troponins
    Sleep Breath, 18 (2), 351-8
    DOI 10.1007/s11325-013-0892-6, PubMed 24043484
  483. Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T (2013)
    [Cardioprotective treatment during adjuvant cancer therapy]
    Tidsskr Nor Laegeforen, 133 (17), 1832-6
    DOI 10.4045/tidsskr.12.1514, PubMed 24042297
  484. Namtvedt SK, Hisdal J, Randby A, Agewall S, Røsjø H, Omland T (2013)
    The author’s reply
    Heart, 100 (1), 81-2
    DOI 10.1136/heartjnl-2013-304648, PubMed 24014283
  485. Limalanathan S, Eritsland J, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P (2013)
    Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR
    PLoS One, 8 (8), e71780
    DOI 10.1371/journal.pone.0071780, PubMed 23977143
  486. Jander N, Gohlke-Bärwolf C, Bahlmann E, Gerdts E, Boman K, Chambers JB, Egstrup K, Nienaber CA, Pedersen TR, Ray S, Rossebø AB, Willenheimer R, Kienzle RP, Wachtell K, Neumann FJ, Minners J (2013)
    Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis
    Heart, 100 (1), 28-33
    DOI 10.1136/heartjnl-2013-304443, PubMed 23969478
  487. Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D (2013)
    [Atrial fibrillation and stroke]
    Tidsskr Nor Laegeforen, 133 (14), 1453-7
    DOI 10.4045/tidsskr.12.0850, PubMed 23929293
  488. von Lueder TG, Atar D, Krum H (2013)
    Diuretic use in heart failure and outcomes
    Clin Pharmacol Ther, 94 (4), 490-8
    DOI 10.1038/clpt.2013.140, PubMed 23852396
  489. Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A (2013)
    Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure
    Hypertension, 62 (3), 526-32
    DOI 10.1161/HYPERTENSIONAHA.113.01452, PubMed 23836798
  490. Kuliczkowski W, Urbaniak J, Hallén J, Woźniak M, Poloński L, Mysiak A, Atar D, Zembala M, Serebruany V (2013)
    Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty
    Kardiol Pol, 71 (5), 453-63
    DOI 10.5603/KP.2013.0091, PubMed 23788085
  491. Frankenstein L, Katus HA, Grundtvig M, Hole T, de Blois J, Schellberg D, Atar D, Zugck C, Agewall S, Norwegian Heart Failure Registry steering committee (2013)
    Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study
    Eur J Clin Pharmacol, 69 (10), 1747-55
    DOI 10.1007/s00228-013-1512-x, PubMed 23743778
  492. Agewall S (2013)
    Sick leave and a smoking ban
    Eur Heart J, 35 (5), 266-7
    DOI 10.1093/eurheartj/eht178, PubMed 23739243
  493. Serebruany VL, Pokov AN, Aradi D, Can M, DiNicolantonio J, Kipshidze N, Atar D (2014)
    Effect of aliskiren and valsartan combination versus aliskiren monotherapy on hemostatic biomarkers in hypertensive diabetics: Aliskiren and Valsartan Impact in Diabetics pilot trial
    Am J Ther, 21 (6), 482-90
    DOI 10.1097/MJT.0b013e31826915ab, PubMed 23698186
  494. von Lueder TG, Sangaralingham SJ, Wang BH, Kompa AR, Atar D, Burnett JC, Krum H (2013)
    Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure
    Circ Heart Fail, 6 (3), 594-605
    DOI 10.1161/CIRCHEARTFAILURE.112.000289, PubMed 23694773
  495. Serebruany V, Atar D (2013)
    Prasugrel: the real-life perspective
    Circ Cardiovasc Qual Outcomes, 6 (3), 253-4
    DOI 10.1161/CIRCOUTCOMES.113.000239, PubMed 23674315
  496. Serebruany VL, Kipshidze N, Pershukov IV, Kuliczkowski W, Carnes J, Atar D (2014)
    Fatal sepsis and systemic inflammatory response syndrome after off-label prasugrel: a case report
    Am J Ther, 21 (6), e229-33
    DOI 10.1097/MJT.0b013e31828fdb1c, PubMed 23665886
  497. Hisdal J, Agewall S, Omland T (2013)
    Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity—the response
    Heart, 99 (13), 969
    DOI 10.1136/heartjnl-2013-303771, PubMed 23661637
  498. Agewall S (2013)
    [New European guidelines for acute and chronic heart failure]
    Lakartidningen, 110 (13-14), 672-3
    PubMed 23634620
  499. Ghanavatian S, Diep LM, Bárány P, Heimbürger O, Seeberger A, Stenvinkel P, Rohani M, Agewall S (2013)
    Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4
    Angiology, 65 (5), 443-9
    DOI 10.1177/0003319713483000, PubMed 23567479
  500. Shuvy M, Atar D, Gabriel Steg P, Halvorsen S, Jolly S, Yusuf S, Lotan C (2013)
    Oxygen therapy in acute coronary syndrome: are the benefits worth the risk?
    Eur Heart J, 34 (22), 1630-5
    DOI 10.1093/eurheartj/eht110, PubMed 23554440
  501. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F, STREAM Investigative Team (2013)
    Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction
    N Engl J Med, 368 (15), 1379-87
    DOI 10.1056/NEJMoa1301092, PubMed 23473396
  502. Hjeltnes G, Hollan I, Førre O, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2013)
    Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor
    Clin Exp Rheumatol, 31 (3), 415-21
    PubMed 23465067
  503. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2013)
    Questionable levels of evidence in new atrial fibrillation guidelines? Reply
    Europace, 15 (3), 461-2
    DOI 10.1093/europace/eus394, PubMed 23430753
  504. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P (2013)
    'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? Reply
    Europace, 15 (3), 460-1
    DOI 10.1093/europace/eus386, PubMed 23430752
  505. Agewall S, Cattaneo M, Collet JP, Andreotti F, Lip GY, Verheugt FW, Huber K, Grove EL, Morais J, Husted S, Wassmann S, Rosano G, Atar D, Pathak A, Kjeldsen K, Storey RF, ESC Working Group on Cardiovascular Pharmacology and Drug Therapy and ESC Working Group on Thrombosis (2013)
    Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
    Eur Heart J, 34 (23), 1708-13, 1713a-1713b
    DOI 10.1093/eurheartj/eht042, PubMed 23425521
  506. Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K (2013)
    Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study
    Int J Cardiol, 168 (3), 2322-7
    DOI 10.1016/j.ijcard.2013.01.060, PubMed 23416018
  507. Verheugt FW, Clemmensen P, Mehran R, Agewall S, Pocock SJ, Goldstein S, Torp-Pedersen C, Simoons ML, Borer JS, Khder YM, Burton P, Deliargyris E, McMurray JJ, Berkowitz SD, Stough WG, Zannad F (2013)
    Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy
    Eur Heart J, 34 (22), 1621-9
    DOI 10.1093/eurheartj/eht013, PubMed 23382466
  508. Agewall S, Tornvall P (2013)
    Thyroid dysfunction in patients with myocardial infarction with normal coronary arteries
    Angiology, 64 (3), 245-6
    DOI 10.1177/0003319712471071, PubMed 23299173
  509. Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, Agewall S, Berkowitz SD, Burton P, Calvo G, Goldstein S, Verheugt FW, Koglin J, O'Connor CM (2013)
    Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges
    Int J Cardiol, 167 (5), 1772-82
    DOI 10.1016/j.ijcard.2012.12.018, PubMed 23298559
  510. Heck SL, Gulati G, Ree AH, Schulz-Menger J, Gravdehaug B, Røsjø H, Steine K, Bratland A, Hoffmann P, Geisler J, Omland T (2012)
    Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial
    Cardiology, 123 (4), 240-7
    DOI 10.1159/000343622, PubMed 23207160
  511. Scheiman JM, Herlitz J, Veldhuyzen van Zanten SJ, Lanas A, Agewall S, Nauclér EC, Svedberg LE, Nagy P (2013)
    Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial
    J Cardiovasc Pharmacol, 61 (3), 250-7
    DOI 10.1097/FJC.0b013e31827cb626, PubMed 23188121
  512. Hall TS, Hallén J, Agewall S, Atar D, Jensen T (2012)
    Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience
    Clin Lab, 58 (9-10), 1029-36
    DOI 10.7754/Clin.Lab.2012.111206, PubMed 23163120
  513. Mentz RJ, Hernandez AF, Stebbins A, Ezekowitz JA, Felker GM, Heizer GM, Atar D, Teerlink JR, Califf RM, Massie BM, Hasselblad V, Starling RC, O'Connor CM, Ponikowski P (2012)
    Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF
    Eur J Heart Fail, 15 (4), 456-64
    DOI 10.1093/eurjhf/hfs188, PubMed 23159547
  514. Heldal M, Atar D (2012)
    Pharmacological conversion of recent-onset atrial fibrillation: a systematic review
    Scand Cardiovasc J Suppl, 47 (1), 2-10
    DOI 10.3109/14017431.2012.740572, PubMed 23067130
  515. Namtvedt SK, Hisdal J, Randby A, Agewall S, Stranden E, Somers VK, Røsjø H, Omland T (2012)
    Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity
    Heart, 99 (1), 30-4
    DOI 10.1136/heartjnl-2012-303009, PubMed 23048165
  516. Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D (2012)
    The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness
    Atherosclerosis, 225 (1), 160-5
    DOI 10.1016/j.atherosclerosis.2012.08.033, PubMed 23014354
  517. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction, Authors/Task Force Members Chairpersons, Thygesen K, Alpert JS, White HD, Biomarker Subcommittee, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, ECG Subcommittee, Chaitman BR, Clemmensen PM, Johanson P, Hod H, Imaging Subcommittee, Underwood R, Bax JJ et al. (2012)
    Third universal definition of myocardial infarction
    J Am Coll Cardiol, 60 (16), 1581-98
    DOI 10.1016/j.jacc.2012.08.001, PubMed 22958960
  518. Abdelnoor M, Eritsland J, Brunborg C, Halvorsen S (2012)
    Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway
    Vasc Health Risk Manag, 8, 505-15
    DOI 10.2147/VHRM.S33627, PubMed 22956878
  519. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG et al. (2012)
    Third universal definition of myocardial infarction
    Circulation, 126 (16), 2020-35
    DOI 10.1161/CIR.0b013e31826e1058, PubMed 22923432
  520. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines-CPG, Document Reviewers (2012)
    2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association
    Europace, 14 (10), 1385-413
    DOI 10.1093/europace/eus305, PubMed 22923145
  521. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D (2012)
    ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    Eur Heart J, 33 (20), 2569-619
    DOI 10.1093/eurheartj/ehs215, PubMed 22922416
  522. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA et al. (2012)
    Third universal definition of myocardial infarction
    Eur Heart J, 33 (20), 2551-67
    DOI 10.1093/eurheartj/ehs184, PubMed 22922414
  523. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, ESC Committee for Practice Guidelines (CPG) (2012)
    2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
    Eur Heart J, 33 (21), 2719-47
    DOI 10.1093/eurheartj/ehs253, PubMed 22922413
  524. Halvorsen S (2012)
    STEMI treatment in areas remote from primary PCI centres
    EuroIntervention, 8 Suppl P, P44-50
    DOI 10.4244/EIJV8SPA8, PubMed 22917789
  525. Atar D, Serebruany VL (2012)
    Conclusion
    Adv Cardiol, 47, 165
    DOI 10.1159/000341140, PubMed 22906911
  526. Serebruany VL, Atar D (2012)
    Introduction. Antiplatelet therapy in ACS and A-Fib
    Adv Cardiol, 47, 1-4
    DOI 10.1159/000338206, PubMed 22906898
  527. Prendergast B, Coope LT, Crijns H, Falkenstein E, Fölsch U, Halvorsen S, Janssens S, Jokinen E, Kroemer HK, Lücke A, Murer H, Nagel E, Neyses L, Perk J, Probst-Hensch N, Rietschel ET, Rütten H, Steingen C, Tedgui A, van Gilst W, Eschenhagen T, Kristensen SD (2012)
    The German Centre for Cardiovascular Research
    Eur Heart J, 33 (9), 1033-36,1036a
    PubMed 22893891
  528. Henareh L, Agewall S (2012)
    2-h postchallenge plasma glucose predicts cardiovascular events in patients with myocardial infarction without known diabetes mellitus
    Cardiovasc Diabetol, 11, 93
    DOI 10.1186/1475-2840-11-93, PubMed 22873202
  529. De Blois J, Stranden E, Jogestrand T, Henareh L, Agewall S (2012)
    Echogenicity of the carotid intima-media complex and cardiovascular risk factors
    Clin Physiol Funct Imaging, 32 (5), 400-3
    DOI 10.1111/j.1475-097X.2012.01134.x, PubMed 22856348
  530. Hodt A, Stugaard M, Hisdal J, Stranden E, Atar D, Steine K (2012)
    Regional LV deformation in healthy individuals during isovolumetric contraction and ejection phases assessed by 2D speckle tracking echocardiography
    Clin Physiol Funct Imaging, 32 (5), 372-9
    DOI 10.1111/j.1475-097X.2012.01139.x, PubMed 22856344
  531. Santos RD, Agewall S (2012)
    Non-alcoholic fatty liver disease and cardiovascular disease
    Atherosclerosis, 224 (2), 324-5
    DOI 10.1016/j.atherosclerosis.2012.07.018, PubMed 22840429
  532. Serebruany VL, Atar D (2012)
    Viewpoint: Central adjudication of myocardial infarction in outcome-driven clinical trials--common patterns in TRITON, RECORD, and PLATO?
    Thromb Haemost, 108 (3), 412-4
    DOI 10.1160/TH12-04-0251, PubMed 22836596
  533. Griffin BA, Agewall S (2012)
    Can increased arterial stiffness in women relative to men be explained by their progressive loss of gluteofemoral fat?
    Atherosclerosis, 224 (2), 320-1
    DOI 10.1016/j.atherosclerosis.2012.05.041, PubMed 22800649
  534. Felker GM, Hasselblad V, Tang WH, Hernandez AF, Armstrong PW, Fonarow GC, Voors AA, Metra M, McMurray JJ, Butler J, Heizer GM, Dickstein K, Massie BM, Atar D, Troughton RW, Anker SD, Califf RM, Starling RC, O'Connor CM (2012)
    Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study
    Eur J Heart Fail, 14 (11), 1257-64
    DOI 10.1093/eurjhf/hfs110, PubMed 22764184
  535. Cioffi G, Cramariuc D, Dalsgaard M, Davidsen ES, Egstrup K, Rossebø AB, de Simone G, Gerdts E (2012)
    Left atrial systolic force and outcome in asymptomatic mild to moderate aortic stenosis
    Echocardiography, 29 (9), 1038-44
    DOI 10.1111/j.1540-8175.2012.01744.x, PubMed 22676207
  536. Hjeltnes G, Hollan I, Førre Ø, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2012)
    Relations of serum COMP to cardiovascular risk factors and endothelial function in patients with rheumatoid arthritis treated with methotrexate and TNF-α inhibitors
    J Rheumatol, 39 (7), 1341-7
    DOI 10.3899/jrheum.111401, PubMed 22660798
  537. Rieck ÅE, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdts E (2012)
    Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events
    Hypertension, 60 (1), 90-7
    DOI 10.1161/HYPERTENSIONAHA.112.194878, PubMed 22647889
  538. Agewall S, DeGroot E, Marcos-Alberca P, Zamorano JL, Barrero AA, Badano LP, Perrone-Filardi P (2012)
    Ultrasound and radiology surrogate endpoints in pharmacological studies
    Atherosclerosis, 224 (1), 12-24
    DOI 10.1016/j.atherosclerosis.2012.03.038, PubMed 22632921
  539. Rossebø AB (2012)
    Is aortic bioprosthesis degeneration influenced by metabolic factors?
    Cardiology, 121 (4), 274-6
    DOI 10.1159/000338565, PubMed 22626909
  540. Halvorsen S, Seljeflot I, Weiss T, Bøhmer E, Arnesen H (2012)
    Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy
    Thromb Res, 130 (3), 495-500
    DOI 10.1016/j.thromres.2012.04.016, PubMed 22607887
  541. Bang CN, Greve AM, Boman K, Egstrup K, Gohlke-Baerwolf C, Køber L, Nienaber CA, Ray S, Rossebø AB, Wachtell K (2012)
    Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study
    Am Heart J, 163 (4), 690-6
    DOI 10.1016/j.ahj.2012.01.026, PubMed 22520536
  542. Atar D, Ong S, Lansberg PJ (2015)
    Expanding the Evidence Base: Comparing Randomized Controlled Trials and Observational Studies of Statins
    Am J Ther, 22 (5), e141-50
    DOI 10.1097/MJT.0b013e318245ce94, PubMed 22487773
  543. Wisløff T, Selmer RM, Halvorsen S, Fretheim A, Norheim OF, Kristiansen IS (2012)
    Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis
    BMC Cardiovasc Disord, 12, 26
    DOI 10.1186/1471-2261-12-26, PubMed 22475076
  544. Agewall S (2012)
    [Troponin can be increased in healthy persons following moderate exercise]
    Lakartidningen, 109 (1-2), 18
    PubMed 22468405
  545. Agewall S, Henareh L (2012)
    Low self-estimated quality of life after myocardial infarction and future cardiovascular risk
    Int J Cardiol, 157 (1), 128-9
    DOI 10.1016/j.ijcard.2012.03.044, PubMed 22459393
  546. Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Devereux RB, Køber L, Ray S, Willenheimer R, Wachtell K (2012)
    Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis: the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
    J Am Coll Cardiol, 59 (13), 1142-9
    DOI 10.1016/j.jacc.2011.12.020, PubMed 22440214
  547. Hjeltnes G, Hollan I, Førre Ø, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2012)
    Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients
    Scand J Rheumatol, 41 (3), 240-2
    DOI 10.3109/03009742.2012.656698, PubMed 22401496
  548. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K, Ohman M, Petrie MC, Sonntag F, Uva MS, Storey RF, Wijns W, Zahger D, European Society of Cardiology (2012)
    [ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)]
    G Ital Cardiol (Rome), 13 (3), 171-228
    DOI 10.1714/1038.11322, PubMed 22395108
  549. Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D (2012)
    Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study
    Am J Hypertens, 25 (6), 644-50
    DOI 10.1038/ajh.2012.12, PubMed 22378036
  550. Melki D, Lind S, Agewall S, Jernberg T (2012)
    Prognostic value of combining high sensitive troponin T and N-terminal pro B-type natriuretic peptide in chest pain patients with no persistent ST-elevation
    Clin Chim Acta, 413 (9-10), 933-7
    DOI 10.1016/j.cca.2012.02.008, PubMed 22366164
  551. Atar D (2012)
    [How to diagnose a heart attack in 2012?]
    Tidsskr Nor Laegeforen, 132 (3), 265-6
    DOI 10.4045/tidsskr.11.1367, PubMed 22314724
  552. Holme I, Pedersen TR, Boman K, Egstrup K, Gerdts E, Kesäniemi YA, Malbecq W, Ray S, Rossebø AB, Wachtell K, Willenheimer R, Gohlke-Bärwolf C (2011)
    A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis
    Heart, 98 (5), 377-83
    DOI 10.1136/heartjnl-2011-300475, PubMed 22155702
  553. Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K (2011)
    Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
    Circulation, 125 (2), 346-53
    DOI 10.1161/CIRCULATIONAHA.111.049759, PubMed 22147903
  554. Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K (2011)
    Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
    Int J Cardiol, 166 (1), 72-6
    DOI 10.1016/j.ijcard.2011.09.064, PubMed 21996417
  555. Wisløff T, Atar D, Sønbø Kristiansen I (2013)
    Cost effectiveness of drug-eluting stents as compared with bare metal stents in patients with coronary artery disease
    Am J Ther, 20 (6), 596-601
    DOI 10.1097/MJT.0b013e3182211a01, PubMed 21822114
  556. Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Hammer-Hansen S, Køber L, Willenheimer R, Wachtell K (2011)
    Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data)
    Am J Cardiol, 108 (4), 541-7
    DOI 10.1016/j.amjcard.2011.03.084, PubMed 21624542
  557. Gerdts E, Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber C, Ray S, Skjærpe T, Wachtell K, Willenheimer R (2010)
    Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)
    Am J Cardiol, 106 (11), 1634-9
    DOI 10.1016/j.amjcard.2010.07.042, PubMed 21094366
  558. Holme I, Boman K, Brudi P, Egstrup K, Gohlke-Baerwolf C, Kesäniemi YA, Malbecq W, Rossebø AB, Wachtell K, Willenheimer R, Pedersen TR (2010)
    Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial
    Am J Cardiol, 105 (12), 1802-8
    DOI 10.1016/j.amjcard.2010.01.363, PubMed 20538134
  559. Lund BP, Gohlke-Bärwolf C, Cramariuc D, Rossebø AB, Rieck AE, Gerdts E (2010)
    Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy)
    Am J Cardiol, 105 (10), 1456-60
    DOI 10.1016/j.amjcard.2009.12.069, PubMed 20451694
  560. Rieck AE, Cramariuc D, Staal EM, Rossebø AB, Wachtell K, Gerdts E (2010)
    Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy)
    J Hypertens, 28 (2), 377-83
    DOI 10.1097/HJH.0b013e328332fa44, PubMed 19844185
  561. Hallén J, Atar D, Serebruany V (2014)
    Effects of FX06 in vitro on platelet, coagulation, and fibrinolytic biomarkers in volunteers and patients with documented coronary artery disease
    Am J Ther, 21 (2), 91-8
    DOI 10.1097/MJT.0b013e3181b0a6ff, PubMed 19770797
  562. Rossebø AB, Gerdts E, Pedersen TR, SEAS Study Steering Committee (2009)
    Aortic valve stenosis
    Lancet, 373 (9680), 2022-3; author reply 2023
    DOI 10.1016/S0140-6736(09)61104-1, PubMed 19524771
  563. Steine K, Rossebø AB, Stugaard M, Pedersen TR (2008)
    Left ventricular systolic and diastolic function in asymptomatic patients with moderate aortic stenosis
    Am J Cardiol, 102 (7), 897-901
    DOI 10.1016/j.amjcard.2008.07.001, PubMed 18805118
  564. Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R, SEAS Investigators (2008)
    Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
    N Engl J Med, 359 (13), 1343-56
    DOI 10.1056/NEJMoa0804602, PubMed 18765433
  565. Cramariuc D, Rieck AE, Staal EM, Wachtell K, Eriksen E, Rossebø AB, Gerdts E (2007)
    Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy)
    Am J Cardiol, 101 (4), 510-5
    DOI 10.1016/j.amjcard.2007.09.100, PubMed 18312768
  566. Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R (2007)
    Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study
    Am J Cardiol, 99 (7), 970-3
    DOI 10.1016/j.amjcard.2006.10.064, PubMed 17398194
  567. Rossebø AB, Pedersen TR (2004)
    Hyperlipidaemia and aortic valve disease
    Curr Opin Lipidol, 15 (4), 447-51
    DOI 10.1097/01.mol.0000137229.00020.fe, PubMed 15243218
  568. Halvorsen S (2015)
    Percutaneous coronary intervention in the patient on oral anticoagulation
    Tidsskr. Nor. Laegeforen., 135 (1), 55
    DOI 10.4045/tidsskr.14.1248
  569. Pope MK, Ghanima W, Atar D (2020)
    Intensification of antithrombotic therapy for chronic atherosclerosis
    Tidsskr. Nor. Laegeforen., 140 (10), 976-977
  570. Rossebo AB, Pedersen TR, Kesaniemi YA (2009)
    Calcific Aortic Stenosis Reply
    N. Engl. J. Med., 360 (1), 85-86
  571. Blichfeldt-AEro SC, Halvorsen S, Trondalen G (2021)
    Music therapy in invasive cardiac procedures: Expanded perspective
    BRIT. J. MUSIC THER., 13594575211039090
    DOI 10.1177/13594575211039090
  572. Rutherford OCW, Konig MSS, Risnes K, Raouf N, Atar D, Ghanima W (2018)
    Serum concentration measurements of DOAK drugs Reply
    Tidsskr. Nor. Laegeforen., 138 (7), 621
  573. Aamodt AH, Bjork MH, Tronvik EA, Buanes EA, Stovner LJ, Atar D (2020)
    Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe Covid-19?
    Tidsskr. Nor. Laegeforen., 140 (9), 859-860
  574. Cioffi G, Cramariuc D, Dalsgaard M, Davidsen ES, Egstrup K, Rossebo AB, de Simone G, Gerdts E (2012)
    Proper Use of Left Atrial Ejection Force as a Measure of Left Atrial Mechanical Function Reply
    Echocardiography-J. Cardiovasc. Ultrasound Allied Tech., 29 (7), 881-882
  575. Blichfeldt-AEro SC, Trondalen G, Halvorsen S (2019)
    Facilitated music listening: Music therapy in an invasive cardiac procedure
    BRIT. J. MUSIC THER., 33 (1), 27-38
    DOI 10.1177/1359457519840131
  576. Atar D, Serebruany VL (2012)
    Antiplatelet Therapy in ACS and A-Fib Conclusion
    Adv.Cardiol., 47, 165
  577. Jander N, Minners J, Neumann FJ, Gohlke-Barwolf C, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Skjaerpe T, Willenheimer R, Wachtell K (2011)
    Response to Letters Regarding Article, "Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction"
    Circulation, 124 (13), E362-E363
    DOI 10.1161/CIRCULATIONAHA.111.045203
  578. Wyller TB, Kjeldsen SE, Halvorsen S, Bath PM, Sandercock P (2020)
    In memoriam Eivind Berge, MD, PhD, 1964-2020: cardiologist, trialist and hypertension/stroke researcher
    J. Hypertens., 38 (6), 1199-1200
    DOI 10.1097/HJH.0000000000002488
  579. Serebruany VL, Atar D (2012)
    Antiplatelet Therapy in ACS and A-Fib Introduction
    Adv.Cardiol., 47, 1-4
  580. Halvorsen S (2016)
    Female hearts A medical textbook about common heart disease
    Tidsskr. Nor. Laegeforen., 136 (4), 333
    DOI 10.4045/tidsskr.15.1299

 
Page visits: 3629